Aspen Aerogels (ASPN) 10-K 8 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 07, 2019	Jun. 30, 2018
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	FY
Trading Symbol	ASPN
Entity Registrant Name	ASPEN AEROGELS INC
Entity Central Index Key	1,145,986
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		24,246,807
Entity Public Float			$ 107.8

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 3,327	$ 10,694
Accounts receivable, net of allowances of $2,877 and $93	25,565	26,764
Inventories	7,318	8,915
Prepaid expenses and other current assets	1,041	1,289
Total current assets	37,251	47,662
Property, plant and equipment, net	61,699	76,067
Other long-term assets	73	86
Total assets	99,023	123,815
Current liabilities:
Accounts payable	12,392	10,653
Accrued expenses	3,864	5,862
Revolving line of credit	4,181	3,750
Deferred revenue	2,629	1,304
Total current liabilities	23,066	21,569
Deferred rent	1,218	1,303
Prepayment liability	4,485
Total liabilities	28,769	22,872
Commitments and contingencies (Note 10)
Stockholders' equity:
Preferred stock, $0.00001 par value; 5,000,000 shares authorized, no shares issued or outstanding at December 31, 2018 and 2017
Common stock, $0.00001 par value; 125,000,000 shares authorized, 23,973,517 and 23,643,189 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively	0	0
Additional paid-in capital	541,839	538,088
Accumulated deficit	(471,585)	(437,145)
Total stockholders' equity	70,254	100,943
Total liabilities and stockholders' equity	$ 99,023	$ 123,815

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Statement Of Financial Position [Abstract]
Allowance for doubtful accounts	$ 2,877	$ 93
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	23,973,517	23,643,189
Common stock, shares outstanding	23,973,517	23,643,189

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue:
Total revenue	$ 104,361	$ 111,631	$ 117,738
Cost of revenue:
Gross profit	12,669	18,671	23,311
Operating expenses:
Research and development	6,319	6,180	5,306
Sales and marketing	13,794	12,604	11,810
General and administrative	19,116	19,023	17,415
Impairment of construction in progress	7,356
Total operating expenses	46,585	37,807	34,531
Loss from operations	(33,916)	(19,136)	(11,220)
Other expense, net:
Interest expense, net	(524)	(185)	(147)
Postponed financing costs			(656)
Total other expense, net	(524)	(185)	(803)
Net loss	$ (34,440)	$ (19,321)	$ (12,023)
Net loss per share:
Basic and diluted	$ (1.45)	$ (0.83)	$ (0.52)
Weighted-average common shares outstanding:
Basic and diluted	23,738,852	23,390,235	23,139,807
Product [Member]
Revenue:
Total revenue	$ 102,123	$ 109,590	$ 115,490
Cost of revenue:
Cost of revenue	90,660	92,052	93,123
Research Services [Member]
Revenue:
Total revenue	2,238	2,041	2,248
Cost of revenue:
Cost of revenue	$ 1,032	$ 908	$ 1,304

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock 0.00001 Par Value [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2015	$ 122,474		$ 527,975	$ (405,501)
Beginning balance, shares at Dec. 31, 2015		23,184,852
Net loss	(12,023)			(12,023)
Stock compensation expense	5,313		5,313
Issuance of restricted stock, shares		75,152
Vesting of restricted stock units	(200)		(200)
Vesting of restricted stock units, shares		109,834
Ending balance at Dec. 31, 2016	115,564		533,088	(417,524)
Ending balance, shares at Dec. 31, 2016		23,369,838
Net loss	(19,321)			(19,321)
Adoption of new accounting standard			300	(300)
Stock compensation expense	5,091		5,091
Issuance of restricted stock, shares		86,023
Retirement of restricted stock, shares		(12,289)
Vesting of restricted stock units	(391)		(391)
Vesting of restricted stock units, shares		199,617
Ending balance at Dec. 31, 2017	100,943		538,088	(437,145)
Ending balance, shares at Dec. 31, 2017		23,643,189
Net loss	(34,440)			(34,440)
Stock compensation expense	4,302		4,302
Issuance of restricted stock, shares		58,062
Vesting of restricted stock units	(551)		(551)
Vesting of restricted stock units, shares		272,266
Ending balance at Dec. 31, 2018	$ 70,254		$ 541,839	$ (471,585)
Ending balance, shares at Dec. 31, 2018		23,973,517

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (34,440)	$ (19,321)	$ (12,023)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,787	10,753	9,853
Impairment of construction in progress	7,356
Provision for bad debt	2,922	455
Postponed financing costs			656
Stock compensation expense	4,302	5,091	5,313
Lease incentives	(121)	(111)
Other		(1)
Changes in operating assets and liabilities:
Accounts receivable	(1,723)	(9,159)	3,089
Inventories	1,597	3,953	(6,336)
Prepaid expenses and other assets	261	411	(19)
Accounts payable	1,557	1,269	105
Accrued expenses	(2,056)	1,821	(2,178)
Deferred revenue	810	261	362
Other liabilities	94	(28)	600
Net cash used in operating activities	(8,654)	(4,606)	(578)
Cash flows from investing activities:
Capital expenditures	(3,593)	(6,118)	(13,216)
Net cash used in investing activities	(3,593)	(6,118)	(13,216)
Cash flows from financing activities:
Proceeds from borrowings under line of credit	56,716	27,250
Repayment of borrowings under line of credit	(56,285)	(23,500)
Prepayment proceeds under customer supply agreement, net	5,000
Postponed financing costs			(656)
Repayment of obligations under capital lease		(27)	(68)
Payments made for employee restricted stock minimum tax withholdings	(551)	(391)	(200)
Net cash provided by (used in) financing activities	4,880	3,332	(924)
Net decrease in cash	(7,367)	(7,392)	(14,718)
Cash and cash equivalents at beginning of period	10,694	18,086	32,804
Cash and cash equivalents at end of period	3,327	10,694	18,086
Supplemental disclosures of cash flow information:
Interest paid	338	220	196
Income taxes paid	0	0	0
Supplemental disclosures of non-cash activities:
Changes in accrued capital expenditures	182	$ (3,681)	$ 2,116
Capitalized interest	$ 44

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Business	(1) Description of Business Nature of Business Aspen Aerogels, Inc. (the Company) is an aerogel technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy infrastructure and building materials markets. The Company also conducts research and development related to aerogel technology supported by funding from several agencies of the U.S. government and other institutions in the form of research and development contracts. The Company maintains its corporate offices in Northborough, Massachusetts. The Company has three wholly owned subsidiaries: Aspen Aerogels Rhode Island, LLC, Aspen Aerogels Germany, GmbH and Aspen Aerogels Georgia, LLC. On June 18, 2014, the Company completed the initial public offering (IPO) of its common stock. Liquidity During the year ended 2018, the Company incurred a net loss of $34.4 million, used $8.7 million of cash in operations and had a cash and cash equivalents balance of $3.3 million and $4.2 million of outstanding borrowings under its revolving line of credit (see note 7). After giving effect to the outstanding borrowings and letters of credit, the additional amount available to the Company at December 31, 2018 under the revolving line of credit was $10.3 million. The Company is making investments to increase capacity at its existing manufacturing facility in East Providence, Rhode Island and to develop new technologies and business opportunities. The Company expects its existing cash balance and the amount anticipated to be available under the existing revolving line of credit will be sufficient to fund a portion of these investments. The Company plans to manage other capital expenditures and working capital balances to maintain the cash resources required to support current operating requirements and to complete the capacity expansion plan. The Company will need to supplement its cash balance and amounts available under its revolving line of credit with anticipated cash flows from operations, debt financings, customer prepayments, technology licensing agreements or equity financings to provide the capital required to complete the expansion of the existing manufacturing facility and to fund its strategic business initiatives.

Summary of Basis of Presentatio

Summary of Basis of Presentation and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Basis of Presentation and Significant Accounting Policies	(2) Summary of Basis of Presentation and Significant Accounting Policies Principles of Consolidation The accompanying consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP), include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Reclassification The statement of cash flows for the year ended December 31, 2017 reflects a $0.5 million reclassification of the Company’s provision for bad debts to an adjustment to reconcile net loss to net cash used in operating activities from a component of changes in accounts receivable. The change has no impact on the results of operations. Use of Estimates The preparation of the consolidated financial statements requires the Company to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, sales returns and allowances, product warranty costs, inventory valuation, the carrying amount of property and equipment, stock-based compensation and deferred income taxes. The Company evaluates its estimates and assumptions on an on-going basis using historical experience and other factors, including the current economic environment, which are believed to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances warrant. Illiquid credit markets, volatile equity markets and declines in business investment can increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. Cash and Cash Equivalents Cash equivalents include short-term, highly liquid instruments, which consist of money market accounts. All cash and cash equivalents are maintained with major financial institutions in North America. Deposits with these financial institutions may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk. Concentration of Credit Risk Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of accounts receivable. The Company’s customers are primarily insulation distributors, insulation contractors, insulation fabricators and select end-users located throughout the world. The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral to secure accounts receivable. The Company maintains an allowance for doubtful accounts based on its assessment of the collectability of accounts receivable. The Company reviews the allowance for doubtful accounts quarterly. During the year ended December 31, 2018, the Company recorded a charge for uncollectible accounts receivable of $2.9 million related to four customers of which one customer accounted for $2.8 million of the charge. Allowance for doubtful accounts was $2.8 and zero at December 31, 2018 and 2017, respectively. The Company does not have any off-balance-sheet credit exposure related to its customers. For the year ended December 31, 2018, one customer represented 20% of total revenue. For the year ended December 31, 2017, two customers represented 15% and 12% of total revenue, respectively. For the year ended December 31, 2016, two customers represented 25% and 15% of total revenue, respectively. At December 31, 2018, the Company had one customer that accounted for 18% of accounts receivable. At December 31, 2017, the Company had three customers that accounted for 19%, 14% and 11% of accounts receivable, respectively. Inventories Inventory consists of finished products and raw materials. Inventories are carried at lower of cost, determined using the first-in, first-out (FIFO) method, and net realizable value. Cost includes materials, labor and manufacturing overhead. Manufacturing overhead is allocated to the costs of conversion based on normal capacity of the Company’s production facility. Abnormal freight, handling costs and material waste is expensed in the period it occurs. The Company periodically reviews its inventories and makes provisions as necessary for estimated excess, obsolete or damaged goods to ensure values approximate the lower of cost and net realizable value. The amount of any such provision is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, selling prices and market conditions. Property, Plant and Equipment, Net Property, plant and equipment are stated at cost. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property, plant and equipment. Interest expense capitalization commences at the time a capital project begins construction and concludes when the project is completed. The Company has capitalized interest costs as part of the historical costs of constructing its manufacturing facilities or significant capital projects. The Company capitalized less than $0.1 million in interest costs related to the capacity expansion project of the existing East Providence, Rhode Island manufacturing facility during the year ended December 31, 2018. The Company did not capitalize interest on projects during the years ended December 31, 2017 or December 31 2016. Depreciation on plant and equipment is calculated on the straight-line method over the estimated useful lives of the assets. Assets related to leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or estimated useful life of the asset. Assets utilized in the Company’s operations that are taken out of service with no future use are charged to cost of revenue or operating expenses, depending on the department in which the asset was utilized. Impairments of construction in progress are charged to operating expenses upon the determination of no future use. Other Assets Other assets primarily include long-term deposits. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recognition and measurement of a potential impairment is performed on assets grouped with other assets and liabilities at the lowest level where identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to future undiscounted net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the fair value of the asset or asset group. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. The Company had previously completed the design and engineering for a second manufacturing facility to be located in Statesboro, Georgia supported by a package of incentives, including free land, from state and local governmental authorities. During 2016, the Company elected to delay construction of the facility due to its assessment of future demand. In December 2018, the local governmental authorities notified the Company that they will exercise their right to terminate the incentive package in February 2019 and to make the identified site available to other parties. In addition, the Company determined that due to its cumulative manufacturing process advancements since 2016 and expected additional improvements in the near future, it will not use the existing design and engineering to construct a second facility in any location. Accordingly, the Company determined that the design and engineering costs are not recoverable and recorded an impairment charge of $7.4 million on construction in progress assets during 2018. Deferred Rent For leases that contain fixed increases in the minimum annual lease payment during the original term of the lease, the Company recognizes rental expense on a straight-line basis over the lease term, and records the difference between rent expense and the amount currently payable as deferred rent. Lease incentives for allowances for qualified leasehold improvements received from landlords are amortized on a straight-line basis over the lease term. The short-term portion of deferred rent is included within accrued expenses on the consolidated balance sheet. Revenue Recognition On January 1, 2018, the Company adopted Accounting Standards Codification 606, Revenue from Contracts with Customers (ASC 606). See note 3 for further details. Warranty The Company provides warranties for its products and records the estimated cost within cost of sales in the period that the related revenue is recorded. The Company’s standard warranty period extends to one year from the date of shipment. This standard warranty provides that the Company’s products will be free from defects in material and workmanship, and will, under normal use, conform to the specifications for the product. The Company’s products may be utilized in systems that involve new technical demands and new configurations. Accordingly, the Company regularly reviews and assesses whether warranty reserves should be recorded in the period the related revenue is recorded. For an initial shipment of product for use in a system with new technical demands or new configurations and where the Company is unsure of meeting the customer’s specifications, the Company will defer the recognition of product revenue and related costs until written customer acceptance is obtained. The Company performs periodic testing of its aerogel blankets to ensure compliance with published performance specifications. From time to time, tests may indicate a product could potentially perform outside of these specifications. At that time, additional testing is initiated or the Company may conduct a root cause investigation. During the year ended December 31, 2018, test results indicated that tested samples performed outside the published performance specifications for a specific attribute of a product. The Company has determined that it is probable it has incurred a liability, however, a liability or range of liability is not estimable as of December 31, 2018. The Company will continue to assess the impact of the testing results on its customer base and, depending on the assessment, could be subject to warranty charges in future periods. The Company did not record any warranty expense during the year ended December 31, 2018. During the years ended December 31, 2017 and 2016, the Company recorded warranty expense of $0.9 million and $0.5 million, respectively. These specific warranty charges were related to product claims for two separate product application issues. These claims were outside of the Company’s typical experience. As of December 31, 2018, the Company had satisfied all outstanding warranty claims. Shipping and Handling Costs Shipping and handling costs are classified as a component of cost of revenue. Customer payments of shipping and handling costs are recorded as product revenue. Stock-based Compensation The Company grants share-based awards to its employees and non-employee directors. All share-based awards granted, including grants of stock options, restricted stock and restricted stock units (RSUs), are recognized in the statement of operations based on their fair value as of the date of grant. Expense is recognized on a straight-line basis over the requisite service period for all awards with service conditions. For performance-based awards, the grant date fair value is recognized as expense when the condition is probable of being achieved, and then on a graded basis over the requisite service period. The Company uses the Black-Scholes option-pricing model to determine the fair value of service-based option awards. The Black-Scholes model requires the use of a number of complex and subjective assumptions including fair value of the underlying security, the expected volatility of the underlying security, a risk-free interest rate and the expected term of the option. The fair value of restricted stock and RSUs is determined using the closing price of the Company’s common stock on the date of grant. All shares of restricted stock are not transferable until vested. Restricted stock is typically issued to non-employee directors and typically vests over a one-year period from the date of issuance. RSUs are issued to employees and typically vest over a three to four year period from the date of issuance. The fair value of restricted stock and RSUs upon which vesting is solely service-based is expensed ratably over the vesting period. If the service condition for shares of restricted stock is not met for any reason, the shares of unvested restricted stock will be forfeited and returned to the Company. For stock options that contain a market condition, the Company uses the Monte-Carlo simulation option-pricing model to determine the fair value of the awards. In addition to the input assumptions used in the Black-Scholes model, the Monte-Carlo simulation option-pricing model factors the probability that the specific market condition may or may not be satisfied into the valuation. Stock-based compensation expense for awards with a market condition is recognized on a straight-line basis over the requisite service period for each such award. Pursuant to the evergreen provisions of the 2014 Employee, Director and Consultant Equity Incentive Plan, the number of shares of common stock authorized for issuance under the plan automatically increased by 472,863 shares to 7,009,460 shares effective January 1, 2018. Research and Development Costs incurred in the research and development of the Company’s products include compensation and related costs, services provided by third-party contractors, materials and supplies and are classified as research and development expenses as incurred. Research and development costs directly associated with research services revenue are classified as research services in cost of revenue. Earnings per Share The Company calculates net loss per common share based on the weighted-average number of common shares outstanding during each period. Potential common stock equivalents are determined using the treasury stock method. The weighted-average number of common shares included in the computation of diluted net income (loss) gives effect to all potentially dilutive common equivalent shares, including outstanding stock options, RSUs and warrants. Common equivalent shares are excluded from the computation of diluted net loss per share if their effect is antidilutive. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. The Company accounts for uncertain tax positions using a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Differences between tax positions taken in a tax return and amounts recognized in the financial statements are recorded as adjustments to income taxes payable or receivable, or adjustments to deferred taxes, or both. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes penalties and interest related to uncertain tax positions, if any, as a component of income tax expense. Segments Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker in making decisions on how to allocate resources and assess performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company’s chief operating decision maker reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company. The Company views its operations and manages its business as one operating segment. Information about the Company’s total revenues, based on shipment destination or services location, is presented in the following table: Year Ended December 31, 2018 2017 2016 (In thousands) Revenue: U.S. $ 41,733 $ 51,439 $ 35,726 International 62,628 60,192 82,012 Total revenue $ 104,361 $ 111,631 $ 117,738 Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, the Company evaluates the pronouncements to determine the potential effects of adoption to its consolidated financial statements. Standards Implemented After December 31, 2017 In August 2015, the FASB issued a deferral of ASU 2014-09, Revenue from Contracts with Customers. The standard replaced the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP with a principle based approach for determining revenue recognition. As a result of the deferral, public entities were required to apply the revised revenue recognition standard for the annual reporting period beginning on or after December 15, 2017, including interim periods within that annual reporting period. The Company adopted this standard using the modified retrospective method on January 1, 2018. The Company completed its analysis of the new revenue standard and determined that it would not materially impact the allocation and timing of recognition of previously reported revenues from the sale of products or performance of research and development services. In addition, the Company determined that there were no incremental contract costs or contract fulfillment costs to be recognized in connection with the adoption. Based on the Company’s analysis, no adjustment to retained earnings was required as of the January 1, 2018 adoption date. Accordingly, the Company’s application of the standard did not have a material impact on the Company’s consolidated balance sheet at January 1, 2018 and did not have a material impact to its statement of operations for the years ended In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15). This amendment addresses eight classification issues related to the statement of cash flows. The amendments in ASU 2016-15 are effective for public business entities for annual and interim periods in fiscal years beginning after December 15, 2017. The Company adopted the provisions of the amendment on January 1, 2018. The adoption of the standard has not resulted in any material impact to the Company’s consolidated financial statements or other disclosures. Standards to be Implemented After December 31, 2018 In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . FASB ASU 2016-02 modifies the accounting for leases and requires that all leases be recorded on the consolidated balance sheets as assets and liabilities. This standard is effective for fiscal years beginning after December 15, 2018.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Revenue from Contracts with Customers	(3) Revenue from Contracts with Customers On January 1, 2018, the Company Adopted Accounting Standards Codification 606, Revenue from Contracts with Customers (ASC 606) using the modified retrospective method for all contracts not completed as of the date of adoption. The adoption of ASC 606 did not have a material impact on the allocation and timing of the recognition of previously reported revenues from the sale of products, subsea projects or performance of research services. In addition, the Company determined that there are no incremental contract costs or contract fulfillment costs associated with the adoption. The reported results for 2018 reflect the application of ASC 606 guidance while the reported results for 2017 were prepared under the guidance of ASC 605. The adoption of ASC 606 represents a change in accounting principle that more closely aligns revenue recognition with the delivery of the Company's product or research services and will provide financial statement readers with enhanced disclosures. Revenue Recognition Revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange from those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the separate performance obligations in the contract; and (v) recognition of the revenue associated with performance obligations as they are satisfied. The Company applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations, and assesses whether each promised good or service is distinct. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. The Company did not have any contracts outstanding at January 1, 2018 and did not enter into any contracts during the year ended The Company records deferred revenue for product sales when the Company has delivered products but other performance obligations have not been satisfied or control has not been transferred to the customer. Shipping and Handling Costs Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs and are included in the cost of product revenue. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these products or research services. Product Revenue The Company generally enters into contracts containing one type of performance obligation. The Company recognizes product revenue when the performance obligation is satisfied, which is generally upon delivery according to contractual shipping terms within customer purchase orders. The Company also enters into rebate agreements with certain customers. These agreements may be considered an additional performance obligation of the Company or variable consideration within a contract. Rebates are recorded as a reduction of revenue in the period the related product revenue is recognized. A corresponding liability is recorded as a component of deferred revenue on the consolidated balance sheets. These arrangements are primarily based on the customer attaining contractually specified sales volumes. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using historical rates of return, current quarter credit sales, and specific items of exposure on a contract by contract basis. Sales return reserves were less than $0.1 million at both December 31, 2018 and December 31, 2017. Subsea Projects The Company manufactures and sells subsea products that are designed for pipe-in-pipe applications in offshore oil production and are typically customized to meet customer specifications. Subsea products typically have no alternative use and contain an enforceable right to payment. Customer invoicing terms for subsea products are typically based on certain milestones within the production and delivery schedule. Under the provisions of ASC 606, the Company recognizes revenue at a point in time when transfer of control of the products is passed to the customer, or During the December 31, 2018 Research Services The Company performs research services under contracts with various government agencies and other institutions. These contracts generally have one type of performance obligation associated with the provision of research services including functional licenses to any resulting intellectual property. The Company records revenue using the percentage-of-completion method in two ways: (1) for firm-fixed-price contracts, the Company accrues that portion of the total contract price that is allocable on the basis of the Company’s estimates of costs incurred to date to total contract costs; and (2) for cost-plus-fixed-fee contracts, the Company records revenue that is equal to total payroll cost incurred times a stated factor plus reimbursable expenses, to a stated upper limit. The primary cost under the Company’s research service contacts is the labor effort expended in completing the research, and the only deliverable, other than the labor hours expended, is the reporting of research results to the customer. Because the input measure of labor hours expended is also reflective of the output measure, it is a reliable means to measure the extent of progress toward completion. Revisions in cost estimates and fees during the course of the contract are reflected in the accounting period in which the facts that require the revisions become known. Contract costs and rates used to allocate overhead to contracts are subject to audit by the respective contracting government agency. Adjustments to revenue as a result of audit are recorded within the period they become known. To date, adjustments to revenue as a result of contracting agency audits have been insignificant Disaggregation of Revenue In the following table, revenue is disaggregated by primary geographical region and source of revenue: Year Ended December 31, 2018 U.S. International Total (In thousands) Geographical region Asia $ — $ 34,597 $ 34,597 Canada — 4,749 4,749 Europe — 19,905 19,905 Latin America — 3,377 3,377 U.S. 41,733 — 41,733 Total revenue $ 41,733 $ 62,628 $ 104,361 Source of revenue Product revenue $ 39,490 $ 54,487 $ 93,977 Subsea projects 5 8,141 8,146 Research services 2,238 — 2,238 Total revenue $ 41,733 $ 62,628 $ 104,361 Contract Balances The following table presents changes in the Company’s contract assets and contract liabilities during the year ended December 31, 2018: Balance at December 31, 2017 Additions Deductions Balance at December 31, 2018 (In thousands) Contract assets Subsea projects $ 2,463 $ 8,555 $ (8,276 ) $ 2,742 Research services 425 2,283 (2,339 ) 369 Total contract assets $ 2,888 $ 10,838 $ (10,615 ) $ 3,111 Contract liabilities Deferred revenue Product revenue $ 1,178 $ 1,890 $ (1,317 ) $ 1,751 Subsea projects 126 7,037 (6,382 ) 781 Research services - 180 (83 ) 97 Prepayment liability - 5,000 (515 ) 4,485 Total contract liabilities $ 1,304 $ 14,107 $ (8,297 ) $ 7,114 During the year ended A contract asset is recorded when the Company satisfies a performance obligation by transferring a promised good or service and has earned the right to consideration from its customer. These assets may represent a conditional or unconditional right to consideration and are included within accounts receivable on the consolidated balance sheets. A contract liability is recorded when consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services under the terms of the contract. Contract liabilities are recognized as revenue after control of the products or services is transferred to the customer and all revenue recognition criteria have been met. Transition Disclosures There was no difference in the accounting for revenue transactions under ASC 606 or ASC 605 as of and for the year ended December 31, 2017. The following tables summarize the impacts of adopting ASC 606 on certain components of the Company’s consolidated financial statements as of and for the year ended Consolidated Balance Sheets As of December 31, 2018 As reported under ASC 606 Pro forma as if ASC 605 was in effect (In thousands) Inventories $ 7,318 $ 10,572 Total current assets 37,251 40,505 Total assets 99,023 102,277 Deferred revenue 2,629 5,759 Total current liabilities 23,066 26,196 Total liabilities 28,769 31,899 Accumulated deficit (471,585 ) (471,461 ) Total stockholders’ equity 70,254 70,378 Total liabilities and stockholders’ equity 99,023 102,277 Total reported assets and liabilities were approximately $3.3 million and $3.1 million, respectively, less than the pro forma consolidated balance sheet which assumes ASC 605 guidance remained in effect as of . Reported inventories and deferred revenue reflect the impact of revenue recognized over time utilizing the input/cost-to-cost method for subsea projects during the year ended . Consolidated Statements of Operations Year Ended December 31, 2018 As reported under ASC 606 Pro forma as if ASC 605 was in effect (In thousands) Product revenue $ 102,123 $ 98,993 Total revenue 104,361 101,231 Product cost of revenue 90,660 87,406 Gross profit 12,669 12,793 Loss from operations (33,916 ) (33,792 ) Net loss (34,440 ) (34,316 ) Total reported product revenue and product cost of revenue were approximately, $3.1 million and $3.3 million, respectively, greater than the pro forma consolidated statement of operations for the year ended December 31, 2018 December 31, 2018 The impact of the adoption of ASC 606 on the consolidated statement of cash flows for the year ended December 31, 2018

Inventories

Inventories	12 Months Ended
	Dec. 31, 2018
Inventory Disclosure [Abstract]
Inventories	(4) Inventories Inventories consist of the following: December 31, 2018 2017 (In thousands) Raw material $ 3,159 $ 2,543 Finished goods 4,159 6,372 Total $ 7,318 $ 8,915

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2018
Property Plant And Equipment [Abstract]
Property, Plant and Equipment, Net	(5) Property, Plant and Equipment, Net Property, plant and equipment consist of the following: December 31, 2018 2017 Useful life (In thousands) Construction in progress $ 1,568 $ 7,699 — Buildings 24,016 24,013 30 years Machinery and equipment 120,466 118,786 3 — 10 years Computer equipment and software 8,352 8,099 3 years Total 154,402 158,597 Accumulated depreciation and amortization (92,703 ) (82,530 ) Property, plant and equipment, net $ 61,699 $ 76,067 Depreciation expense was $10.8 million, $10.8 million and $9.8 million for the years ended December 31, 2018, 2017 and 2016, respectively. Amortization associated with assets under capital leases was less than $0.1 million for years ended December 31, 2017 and 2016. The Company had no assets under capital leases during the year ended December 31, 2018. Construction in progress totaled $1.6 million and $7.7 million at December 31, 2018 and 2017, respectively. The balance at December 31, 2017 included engineering designs and other pre-construction costs totaling $7.2 million for a planned manufacturing facility in Statesboro, Georgia. In addition, construction in progress included $1.2 million and less than $0.1 million at December 31, 2018 and 2017, respectively, related to projects associated with the Company’s plan to expand the capacity of the East Providence, Rhode Island facility. The Company had previously completed the design and engineering for a second manufacturing facility to be located in Statesboro, Georgia supported by a package of incentives, including free land, from state and local governmental authorities. During 2016, the Company elected to delay construction of the facility due to its assessment of future demand. In December 2018, the local governmental authorities notified the Company that they will exercise their right to terminate the incentive package in February 2019 and to make the identified site available to other parties. In addition, the Company determined that due to its cumulative manufacturing process advancements since 2016 and expected additional improvements in the near future, it will not use the existing design and engineering to construct a second facility in any location. Accordingly, the Company determined that the design and engineering costs are not recoverable and recorded an impairment charge of on construction in progress assets during 2018

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2018
Payables And Accruals [Abstract]
Accrued Expenses	(6) Accrued Expenses Accrued expenses consist of the following: December 31, 2018 2017 (In thousands) Employee compensation $ 2,750 $ 4,633 Other accrued expenses 1,114 1,229 Total $ 3,864 $ 5,862

Revolving Line of Credit

Revolving Line of Credit	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Revolving Line of Credit	(7) Revolving Line of Credit The Company is party to an Amended and Restated Loan and Security Agreement with Silicon Valley Bank (Loan Agreement). On January 25, 2018, the Loan Agreement was amended to extend the maturity date of the facility to April 28, 2018. On April 25, 2018, the Loan Agreement was further amended to extend the maturity date of the facility to April 28, 2019. Under the Loan Agreement, the Company may borrow up to $20.0 million subject to compliance with certain covenants and borrowing base limitations. At the Company’s election, the interest rate applicable to borrowings may be based on the prime rate or LIBOR. Prime rate-based rates vary from prime rate plus 0.75% per annum to prime rate plus 2.00% per annum, while LIBOR-based rates vary from LIBOR plus 3.75% per annum to LIBOR plus 4.25% per annum. In addition, the Company is required to pay a monthly unused line fee of 0.5% per annum of the average unused portion of the facility. Obligations under the Loan Agreement are secured by a security interest in all assets of the Company, including those at the East Providence facility, except for certain exclusions. During the year ended December 31, 2018, the Company borrowed $56.7 million and repaid $56.3 million under the line of credit. At December 31, 2018 and 2017, the Company had $4.2 million and $3.8 million drawn on the revolving credit facility. Under the Loan Agreement, the Company is required to comply with both non-financial and financial covenants, including minimum Adjusted EBITDA and minimum Adjusted Quick Ratio covenants, as defined. In May 2018, August 2018 and November 2018, the Company obtained a waiver from Silicon Valley Bank related to its compliance with the Adjusted Quick Ratio covenant. These waivers were subject to the Company’s meeting certain conditions, including, in the case of the November 2018 waiver, the Company’s issuance of $3.25 million in equity or receipt of $5.0 million in customer advanced payments on or before January 31, 2019. The Company met the conditions of the November 2018 waiver upon receipt on January 30, 2019 of a $5.0 million prepayment from BASF. In December 2018, the Company obtained and subsequently met the conditions of a waiver from Silicon Valley Bank related to its compliance with the minimum Adjusted EBITDA covenant. The Company was in compliance with all non-financial and financial covenants as of December 31, 2018 under the terms of the waivers. The Company has been required to provide letters of credit to secure obligations under certain commercial contracts. The Company had outstanding letters of credit backed by the revolving credit facility of $1.6 million and $2.3 million at December 31, 2018 and 2017, respectively, which reduce the funds otherwise available to the Company under the facility. At December 31, 2018, the effective amount available to the Company under the revolving credit facility was $10.3 million after giving effect to the $4.2 million in outstanding borrowings and $1.6 million of outstanding letters of credit.

Other Expense, Net

Other Expense, Net	12 Months Ended
	Dec. 31, 2018
Other Expense Disclosure Nonoperating [Abstract]
Other Expense, Net	(8) Other Expense, net For the years ended December 31, 2018 and 2017, other expense, net of $0.5 million and $0.2 million, respectively, consisted primarily of fees and interest expense related to the Company’s revolving credit facility with Silicon Valley Bank. For the year ended December 31, 2016, other expense, net of $0.8 million consisted of $0.7 million of postponed financing costs related to the Company’s decision to delay the construction and to terminate the financing of a second manufacturing facility during the year and $0.1 million of interest expense related to the revolving credit facility with Silicon Valley Bank.

Deferred Rent

Deferred Rent	12 Months Ended
	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Deferred Rent	(9) Deferred Rent The Company leases office and warehouse space in Northborough, Massachusetts and East Providence Rhode Island. For leases that contain fixed increases in the minimum annual lease payments during the term of the lease, the Company recognizes rental expense on a straight-line basis over the lease term, and records the difference between rent expense and the amount currently payable in deferred rent. Deferred rent consists of the following: December 31, 2018 2017 (In thousands) Deferred rent $ 1,368 $ 1,511 Current maturities of deferred rent (150 ) (208 ) Deferred rent, less current maturities $ 1,218 $ 1,303

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	(10) Commitments and Contingencies Operating Leases During 2016, the Company entered into an agreement to extend its lease of approximately 51,650 square feet of office space in Northborough, Massachusetts. The lease commenced on January 1, 2017 and will expire on December 31, 2026. The annual base rent associated with the lease was $408,000 during 2017 and will increase by approximately 3% annually for the term of the lease. The lease also requires the payment by the Company of its pro rata share of real estate taxes and certain other expenses. Prior to the expiration of the lease, the Company will have the right to extend the lease for an additional term of three years. Under the terms of the lease extension, the landlord provided the Company with an allowance of $1.2 million to be utilized for improvements to the leased premises. These amounts are recorded as a component of deferred rent in determining the minimum lease payments for the property. At December 31, 2018 and 2017, the Company had capitalized $1.2 million in associated leasehold improvement costs. The Company also leases facilities and equipment under operating leases expiring at various dates through 2024. Under these agreements, the Company is obligated to pay annual rent, real estate taxes, and certain operating expenses. Future minimum lease payments under operating leases at December 31, 2018 are as follows: Year Operating Leases (In thousands) 2019 $ 1,375 2020 1,304 2021 1,124 2022 1,068 2023 1,082 Thereafter 1,701 Total minimum lease payments $ 7,654 The Company incurred rent expense under all operating leases of approximately $1.5 million, $1.4 million and $1.5 million in the years ended December 31, 2018, 2017 and 2016, respectively. Letters of Credit The Company has been required to provide certain customers with letters of credit securing obligations under commercial contracts. The Company had letters of credit outstanding of $1.6 million and $2.3 million at December 31, 2018 and 2017, respectively. These letters of credit are secured by the Company’s revolving credit facility (see note 7). Customer Supply Agreement The Company is party to a supply agreement, as amended, with BASF Polyurethanes GmbH (BASF) (the Supply Agreement) and a joint development agreement with BASF SE (the JDA). Pursuant to the Supply Agreement, the Company will sell exclusively to BASF the Company’s Spaceloft A2 product at annual volumes to be specified by BASF, subject to certain volume limits. The Supply Agreement will terminate on December 31, 2027. Upon expiration of the Supply Agreement, the Company will be subject to a post-termination supply commitment for an additional two years. The JDA is designed to facilitate the collaboration between the parties on the development and commercialization of new products. In addition, BASF, in its sole discretion, may make prepayments to the Company in the aggregate amount of up to $22.0 million during the term of the Supply Agreement. BASF agreed to make prepayments in the amount of $5.0 million to the Company in 2018 (the 2018 Prepayment). The amounts and terms of additional prepayments, if any, are subject to negotiation between the Company and BASF. After January 1, 2019, the Company will, at BASF’s instruction, credit up to 25.3% of any amounts invoiced by the Company for Spaceloft A2 product sold to BASF against the 2018 Prepayment balance. However, BASF has no obligation to purchase products under the Supply Agreement. If any of the 2018 Prepayment remains uncredited as of December 31, 2021, BASF may request that the Company repay the uncredited amount to BASF. The prepayment obligation is secured by a security interest in real estate, plant and equipment at the Company’s Rhode Island facility and a license to certain intellectual property. As of December 31, 2018, the Company had recorded the 2018 Prepayment of $5.0 million as a prepayment liability, net of the current portion of $0.5 million which is included within deferred revenue on the consolidated balance sheet. Litigation The Company is, from time to time, a party to litigation that arises in the normal course of its business operations. See Part I, Item 3 (“Legal Proceedings”) of this Annual Report on Form 10-K for a description of certain of the Company’s current legal proceedings. The Company is not presently a party to any litigation for which it believes a loss is probable requiring an amount to be accrued or a possible loss contingency requiring disclosure.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Stockholders' Equity	(11) Stockholders’ Equity At December 31, 2018 and 2017, the Company was authorized to issue 130,000,000 shares of stock, of which 125,000,000 shares were designated as common stock and 5,000,000 shares were designated as preferred stock.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2018
Postemployment Benefits [Abstract]
Employee Benefit Plan	(12) Employee Benefit Plan The Company sponsors the Aspen Aerogels, Inc. 401(k) Plan. Under the terms of the plan, the Company’s employees may contribute a percentage of their pretax earnings. During each of the years ended December 31, 2018, 2017 and 2016, the Company provided matching contributions of $0.2 million.

Employee Stock Ownership Plans

Employee Stock Ownership Plans	12 Months Ended
	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Employee Stock Ownership Plans	(13) Employee Stock Ownership Plans Effective June 12, 2014, the Company adopted the 2014 Employee, Director and Consultant Equity Incentive Plan (the 2014 Equity Plan). Under the 2014 Equity Plan, the Company may grant incentive stock options (ISOs), non-qualified stock options (NSOs), restricted stock, restricted stock units (RSUs) and other stock-based awards. Stock options under the plan are to be granted with an exercise price not less than the fair market value of the Company’s common stock at the date of grant. Equity awards granted to employees generally vest over a service period of three to four years. Restricted stock and stock options granted to nonemployee directors generally vest over a one year service period. During 2018, the Company granted 58,062 shares of restricted common stock with a grant date fair value of $0.3 million and 81,102 NSOs to purchase shares of common stock with a grant date fair value of $0.4 million to its non-employee directors. The awards to non-employee directors during 2018 will vest over a period of one year. The Company also granted 497,910 RSUs with a grant date fair value of $2.3 million and 493,154 NSOs to purchase shares of common stock with a grant date fair value of $1.1 million to employees. The RSUs and NSOs granted to employees during 2018 will vest over a three year period. All awards to nonemployee directors and employees during 2018 were granted under the 2014 Equity Plan. On December 11, 2015, the Company issued certain equity grants to its chief executive officer which included 78,125 shares of restricted stock, 84,745 NSOs to purchase shares of common stock vesting solely over three years and 370,181 NSOs to purchase shares of common stock vesting subject to certain common stock price target achievements, as defined, over a three to five year period (the CEO Options). Collectively, these equity grants had an aggregate fair value of $2.0 million at the time of grant. The restricted stock award will vest based on achievement of a Company financial performance target for fiscal year 2020. On August 2, 2017, the Company modified the performance target for the year ending December 31, 2020 with respect to 78,125 shares of restricted stock held by its chief executive officer. In addition, the Company modified the vesting conditions of 131,578 and 122,324 NSOs held by its chief executive officer to purchase shares of common stock to extend the time period to achieve certain common stock price targets by an additional year to four and five years from the date of grant, respectively. The Company accounted for the extension of the time periods for the achievement of the common stock price target vesting conditions of the NSOs as modifications in determining the stock-based compensation expense to be recognized over the remaining service period. The total incremental compensation expense resulting from the modification was $0.1 million. The incremental compensation expense associated with these awards will be recognized over the remaining service period of the awards. On November 7, 2018, the Company modified the vesting conditions of the CEO Options such that in the event of a change in control, all the outstanding NSOs would vest, regardless of whether or not the common stock price target vesting conditions of the NSOs are achieved. The total incremental compensation expense resulting from the modification was approximately $0.1 million which will be recognized over the remaining term of the options. Stock-based compensation is included in cost of sales or operating expenses, as applicable, and consists of the following: Year Ended December 31, 2018 2017 2016 (In thousands) Cost of product revenue $ 577 $ 790 $ 796 Research and development expenses 461 555 594 Sales and marketing expenses 815 1,096 1,066 General and administrative expenses 2,449 2,650 2,857 Total stock-based compensation $ 4,302 $ 5,091 $ 5,313 At December 31, 2018, 3,780,217 shares of common stock were reserved for issuance upon the exercise or vesting, as appropriate, of outstanding stock-based awards granted under the 2014 Equity Plan. In addition, at December 31, 2018, 89,465 shares of common stock were reserved issuance upon the exercise of outstanding options granted under the Company’s 2001 Equity Incentive Plan, as amended (the 2001 Equity Plan). Any cancellations or forfeitures of the options outstanding under the 2001 Equity Plan will result in the shares reserved for issuance upon exercise or such options becoming available for grant under the 2014 Equity Plan. At December 31, 2018, there were 1,815,982 shares available for future grant under the 2014 Equity Plan. Stock Options Valuation and Amortization Method The fair value of each stock option is estimated as of the date of grant using the Black-Scholes option pricing model. Key inputs into this formula included expected term, expected volatility, expected dividend yield and the risk-free rate. Each assumption is set forth and discussed below. The Company used a Monte Carlo Simulation model to estimate the original grant date fair value of the CEO Options as well as the 2017 and 2018 modifications. The simulation model was based on the Black-Scholes option pricing model and a number of complex assumptions including (i) whether the vesting condition is satisfied within the time-vesting periods, and (ii) the date the common stock price target is met per the terms of the agreement. For stock options with a service condition, the fair value is amortized on a straight-line basis over the requisite service period of the options, which is generally a three- to four-year vesting period from the date of grant. Expected Term The expected term represents the period that the Company’s stock-based awards are expected to be outstanding. The Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Accordingly, the Company uses the simplified method to calculate the expected term for options granted. Expected Volatility Due to the Company’s limited historical data, the Company’s uses an estimated volatility based on the historical volatility of comparable companies with publicly available share prices. In 2018, 2017 and 2016, the expected volatility is based on the weighted average volatility of up to 17 companies with business, financial and market attributes that the Company believes are similar to its own. Expected Dividend The Company uses an expected dividend yield of zero. The Company does not intend to pay cash dividends on its common stock in the foreseeable future, nor has it paid dividends on its common stock in the past. Risk-free Interest Rate The Company uses a risk-free interest rate based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. Estimated Forfeitures Effective January 1, 2017, the Company adopted the provisions of ASU 2016-09 related to the timing of accounting for the forfeitures of share based awards using a modified retrospective transition method. Under these provisions, the Company records the impact of forfeitures of service based awards at the time an award is forfeited. Adoption of the provisions resulted in a cumulative-effect adjustment to equity as of January 1, 2017 of $0.3 million. Prior to adopting ASU 2016-09, forfeitures were required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Forfeitures were estimated based on voluntary termination behavior as well as analysis of actual option forfeitures. Accordingly, share-based compensation expense had been reduced by an estimated annual forfeiture rate for the year ended December 31, 2016. Assumptions Utilized The following information relates to the fair value of the option awards estimated by use of the Black-Scholes option pricing model: Year Ended December 31, 2018 2017 2016 (In thousands) Weighted average assumptions: Expected term (in years) 5.93 5.86 5.86 Expected volatility 47.68 % 51.95 % 53.56 % Risk free rate 2.76 % 1.99 % 1.36 % Expected dividend yield 0.00 % 0.00 % 0.00 % Weighted average fair value: Grant-date fair value of options granted $ 2.29 $ 2.08 $ 2.16 Grant-date fair value of options vested $ 3.29 $ 3.98 $ 7.58 Aggregate intrinsic value of options exercised $ — $ — $ — Outstanding Options The following table summarizes information about stock options outstanding: Number of Shares Weighted Average Grant Date Fair Value Per Share Weighted Average Exercise Price Per Share Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value ($ in thousands, except share and per share data) Options outstanding at December 31, 2017 2,432,906 $ 7.18 $ 10.48 7.64 $ 554,236 Granted 574,256 $ 2.29 $ 4.73 Forfeited (12,710 ) $ 11.65 $ 16.07 Exercised — $ — $ — $ — Options outstanding at December 31, 2018 2,994,452 $ 6.22 $ 9.34 7.11 $ — Exercisable at December 31, 2018 1,743,482 $ 8.87 $ 12.40 6.32 $ — Expected to vest at December 31, 2018 1,250,970 $ 2.53 $ 5.08 8.22 $ — As of December 31, 2018, total unrecognized compensation cost related to non-vested service-based options granted under the 2014 Equity Plan was $1.7 million. The unrecognized compensation cost for the service-based options is expected to be recognized over a weighted average period of 1.75 years. Restricted Stock Awards and Restricted Stock Units The Company values restricted stock awards and RSUs based on the closing price of our shares on the date of grant. RSUs have time-based vesting conditions and typically vest over three or four years. Restricted stock awards issued to nonemployee directors generally vest in full one year from the date of grant. Information related to grants of RSUs during 2018 is as follows: Restricted Stock Units Weighted Average Grant Date Fair Value Balance at December 31, 2017 827,391 $ 4.59 Granted 497,910 4.62 Vested (391,989 ) 5.13 Forfeited (58,085 ) 4.31 Balance at December 31, 2018 875,227 $ 4.38 Restricted stock awards granted during 2018 are considered issued and outstanding common stock and are excluded from the table above. As of December 31, 2018 there were 136,187 shares of restricted stock outstanding. The total intrinsic value of restricted stock and RSUs that vested in 2018 and 2017 was $0.8 million and $1.4 million, respectively. As of December 31, 2018, 933,289 of the total shares of restricted stock and RSUs outstanding will vest upon the fulfillment of service conditions. In addition, 78,125 shares of restricted stock will vest only if a certain performance condition is achieved. As of December 31, 2018, the Company had determined that the performance-based condition was probable and $0.2 million in compensation expense was recorded to date in conjunction with the award. As of December 31, 2018, total unrecognized compensation cost related to restricted stock awards of $0.1 million, RSUs of $2.3 million and restricted stock with performance-based conditions of $0.1 million is expected to be recognized over a weighted average period of 0.47 years, 1.80 years and 2.00 years, respectively.

Net Loss Per Share

Net Loss Per Share	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Net Loss Per Share	(14) Net Loss Per Share The computation of basic and diluted net loss per share consists of the following: Year ended December 31, 2018 2017 2016 (In thousands, except share and per share data) Numerator: Net loss $ (34,440 ) $ (19,321 ) $ (12,023 ) Denominator: Weighted average shares outstanding, basic and diluted 23,738,852 23,390,235 23,139,807 Net loss per share, basic and diluted $ (1.45 ) $ (0.83 ) $ (0.52 ) Potentially dilutive common shares that were excluded from the computation of diluted net loss per share because they were anti-dilutive consist of the following: Year ended December 31, 2018 2017 2016 Common stock options 2,994,452 2,432,906 2,063,574 Restricted common stock units 875,227 827,391 682,085 Common stock warrants — — 115 Restricted common stock awards 136,187 151,859 153,277 Total 4,005,866 3,412,156 2,899,051 In the table above, anti-dilutive shares consist of those common stock equivalents that have (i) an exercise price above the average stock price for the period or (ii) related average unrecognized stock compensation expense sufficient to buy back the entire amount of shares. The Company excludes the shares issued in connection with restricted stock awards from the calculation of basic weighted average common shares outstanding until the restrictions lapse. As of December 31, 2018 and 2017, there was no dilutive impact of the common stock options, RSUs, common stock warrants and restricted stock awards.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	(15) Income Taxes The Company incurred net operating losses and recorded a full valuation allowance against net deferred assets for all periods presented. Accordingly, the Company has not recorded a provision for federal or state income taxes. The reconciliation between the U.S. statutory income tax rate and the Company’s effective rate consists of the following: Year Ended December 31, 2018 2017 2016 U.S. federal income tax statutory rate 21 % 35 % 35 % Permanent differences — % (3 )% (4 )% State tax, net of federal benefit 2 % (5 )% (1 )% Changes in valuation allowance for deferred tax assets (22 )% 113 % (30 )% Stock-based compensation — % — % (1 )% 2017 Tax Cuts and Jobs Act — % (138 )% — % Other (1 )% (2 )% 1 % Effective tax rate — — — The tax effects of temporary differences between financial statement and tax accounting that gave rise to significant portions of the Company’s deferred tax assets and deferred tax liabilities at December 31, 2018 and 2017 are presented below: December 31, 2018 2017 (In thousands) Deferred tax assets: Net operating loss carryforwards $ 51,629 $ 45,307 Stock-based compensation 5,194 4,719 Tax credit carryforwards 296 308 Reserves and accruals 1,258 492 Interest expense limitation 135 — Intangible assets and amortization 50 56 Total gross deferred tax assets 58,562 50,882 Deferred tax liabilities: Depreciation (4,614 ) (4,645 ) Total deferred tax liabilities (4,614 ) (4,645 ) Total deferred tax assets and liabilities 53,948 46,237 Valuation allowance (53,948 ) (46,237 ) Net deferred tax asset $ — $ — On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (TCJA) tax reform legislation. This legislation makes significant change in U.S. tax law including a reduction in the corporate tax rates, changes to net operating loss carryforwards and carrybacks, and a repeal of the corporate alternative minimum tax. The legislation reduced the U.S. corporate tax rate from 34% to 21% for the year ending 2018. As a result of the enacted law, the Company was required to revalue deferred tax assets and liabilities at the 21% rate as of December 31, 2017. This resulted in a decrease in the Company’s net deferred tax asset and corresponding valuation allowance of $26.7 million. As the Company maintains a full valuation allowance against its net deferred tax asset position in the United States, this revaluation did not result in an income tax expense or benefit in the prior year. The provisions of the TCJA related to the one-time mandatory transition tax on deemed repatriation did not have an impact on the Company’s results of operations during the years ended December 31, 2018 and 2017. The other provisions of the TCJA did not have a material impact on the Company’s 2018 or 2017 consolidated financial statements. The Company is subject to additional requirements of the TCJA which became effective during the year ended December 31, 2018. The change in tax law allows post-2017 federal net operating losses to be carried forward indefinitely and allows such net operating losses to offset up to 80% of future taxable income. The Company is also subject to the rules regarding global intangible low-taxed income (“GILTI”), which the Company has elected to account for as a period cost, the limitation on the deductibility of certain executive compensation and interest expense and other immaterial provisions. The net change in the valuation allowance for the year ended December 31, 2018, was an increase of $7.7 million. The Company has recorded a full valuation allowance against its deferred tax assets due to the uncertainty associated with the utilization of the net operating loss carryforwards and other future deductible items. In assessing the realizability of deferred tax assets, the Company considers all available evidence, historical and prospective, with greater weight given to historical evidence, in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the Company’s deferred tax assets generally is dependent upon generation of future taxable income. At December 31, 2018, the Company had $223.1 million of net operating losses available to offset future federal income, if any, of which $194.6 million expire on various dates through December 31, 2037. Net operating losses of $28.5 million generated during the year ended December 31, 2018 have an unlimited carryforward . At December 31, 2018, the Company has $82.1 million of apportioned net operating losses available to offset future state taxable income, if any, and which begin to expire at various dates between 2019 and 2038. For each of the years ended December 31, 2018, 2017 and 2016, the Company did not have any material unrecognized tax benefits and thus no interest and penalties related to unrecognized tax benefits were recorded. In addition, the Company does not expect that the amount of unrecognized tax benefits will change significantly within the next twelve months. The Company files a federal income tax return in the United States and income tax returns in various state and foreign jurisdictions. All tax years are open for examination by the taxing authorities for both federal and state purposes. The Securities & Exchange Commission staff issued Staff Accounting Bulletin No. 118 (SAB 118) to address the tax reform legislation. In accordance with SAB 118, the Company has recognized the provisional tax impacts, outlined above, related to the re-measurement of its deferred income tax assets and liabilities associated with the one-time mandatory transition tax on deemed repatriation. The ultimate impact may differ from the provisional amounts, due to, among other things, the significant complexity of the 2017 Tax Act and anticipated additional regulatory guidance that may be issued by the IRS, changes in analysis, interpretations and assumptions the Company has made and actions the Company may take as a result of the 2017 Tax Act. The Company has completed its review of the 2017 Tax Act and noted no material changes to its initial assessment.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	(16) Subsequent Events The Company has evaluated subsequent events through March 8, 2019, the date of issuance of the consolidated financial statements for the year ended December 31, 2018. On January 14, 2019, the Company entered into an addendum to its existing supply agreement with BASF. Pursuant to the addendum, BASF remitted a prepayment in the amount of $5.0 million to the Company during January 2019. fter January 1, 2020 After December 31, 2022, BASF may elect to have the Company credit 24.7% of any amounts we invoice for Spaceloft A2 sold to BASF against the outstanding balance of this 2019 prepayment, if any, or request that the Company repay the uncredited amount of the 2019 prepayment to BASF in full. On March 4, 2019, the Company’s revolving credit facility with Silicon Valley Bank was amended to extend the maturity date of the facility to April 28, 2020. Under the Company’s revolving credit facility, it is permitted to borrow a maximum of $20.0 million, subject to continued covenant compliance and borrowing base requirements. At the Company’s election, the interest rate applicable to borrowings under the revolving credit facility may be based on the prime rate or LIBOR. Prime rate-based rates vary from prime rate plus 0.75% per annum to prime rate plus 2.00% per annum, while LIBOR-based rates vary from LIBOR plus 3.75% per annum to LIBOR plus 4.25% per annum. In addition, the Company is required to pay a monthly unused revolving line facility fee of 0.5% per annum of the average unused portion of the revolving credit facility. The credit facility has also been amended to (i) revise the definition of “Borrowing Base” to remove the eligible inventory component of the Borrowing Base, (ii) remove the Adjusted Quick Ratio financial covenant set forth in the loan agreement and (iii) establish certain minimum Adjusted EBITDA levels with respect to the minimum Adjusted EBITDA financial covenant for the extended term. The Company intends to extend or replace the facility prior to its maturity.

Quarterly Results of Operations

Quarterly Results of Operations	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Quarterly Results of Operations	QUARTERLY RESULTS OF OPERATIONS Three Months Ended March 31, June 30, Sept 30, Dec 31, (in thousands, except per share data) (unaudited) 2018 Total revenue $ 23,074 $ 21,671 $ 23,937 $ 35,679 Gross profit 2,810 2,744 1,529 5,586 Loss from operations (6,750 ) (6,855 ) (6,369 ) (13,942 ) Net loss (6,842 ) (6,958 ) (6,532 ) (14,108 ) Net loss per share basic and diluted common share - basic $ (0.29 ) $ (0.29 ) $ (0.27 ) $ (0.59 ) 2017 Total revenue $ 23,002 $ 25,069 $ 27,198 $ 36,362 Gross profit 2,221 3,694 4,948 7,808 Loss from operations (9,052 ) (5,433 ) (3,030 ) (1,621 ) Net loss (9,078 ) (5,472 ) (3,088 ) (1,683 ) Net income loss per share basic and diluted common share - basic $ (0.39 ) $ (0.23 ) $ (0.13 ) $ (0.07 )

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2018
Valuation And Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	Schedule II VALUATION AND QUALIFYING ACCOUNTS (in thousands) Description Balance at Beginning of Year Charges to Costs and Expenses (a) Recoveries of Costs and Expenses (b) Deductions to Allowances for Uncollectible Accounts (c) Charges to (Deductions from) Other Accounts (d) Balance at End of Year Year Ended December 31, 2018: Allowances for uncollectible accounts and sales returns and allowances $ 93 2,961 (39 ) (142 ) 4 $ 2,877 Year Ended December 31, 2017: Allowances for uncollectible accounts and sales returns and allowances $ 93 — — — — $ 93 Year Ended December 31, 2016: Allowances for uncollectible accounts and sales returns and allowances $ 89 — — — 4 $ 93 (a) (b) Represents recoveries of allowances for uncollectible accounts established through general and administrative expenses. (c) (d)

Description of Business (Polici

Description of Business (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Nature of Business	Nature of Business Aspen Aerogels, Inc. (the Company) is an aerogel technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy infrastructure and building materials markets. The Company also conducts research and development related to aerogel technology supported by funding from several agencies of the U.S. government and other institutions in the form of research and development contracts. The Company maintains its corporate offices in Northborough, Massachusetts. The Company has three wholly owned subsidiaries: Aspen Aerogels Rhode Island, LLC, Aspen Aerogels Germany, GmbH and Aspen Aerogels Georgia, LLC. On June 18, 2014, the Company completed the initial public offering (IPO) of its common stock.
Liquidity	Liquidity During the year ended 2018, the Company incurred a net loss of $34.4 million, used $8.7 million of cash in operations and had a cash and cash equivalents balance of $3.3 million and $4.2 million of outstanding borrowings under its revolving line of credit (see note 7). After giving effect to the outstanding borrowings and letters of credit, the additional amount available to the Company at December 31, 2018 under the revolving line of credit was $10.3 million. The Company is making investments to increase capacity at its existing manufacturing facility in East Providence, Rhode Island and to develop new technologies and business opportunities. The Company expects its existing cash balance and the amount anticipated to be available under the existing revolving line of credit will be sufficient to fund a portion of these investments. The Company plans to manage other capital expenditures and working capital balances to maintain the cash resources required to support current operating requirements and to complete the capacity expansion plan. The Company will need to supplement its cash balance and amounts available under its revolving line of credit with anticipated cash flows from operations, debt financings, customer prepayments, technology licensing agreements or equity financings to provide the capital required to complete the expansion of the existing manufacturing facility and to fund its strategic business initiatives.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP), include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Reclassification	Reclassification The statement of cash flows for the year ended December 31, 2017 reflects a $0.5 million reclassification of the Company’s provision for bad debts to an adjustment to reconcile net loss to net cash used in operating activities from a component of changes in accounts receivable. The change has no impact on the results of operations.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements requires the Company to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, sales returns and allowances, product warranty costs, inventory valuation, the carrying amount of property and equipment, stock-based compensation and deferred income taxes. The Company evaluates its estimates and assumptions on an on-going basis using historical experience and other factors, including the current economic environment, which are believed to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances warrant. Illiquid credit markets, volatile equity markets and declines in business investment can increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents include short-term, highly liquid instruments, which consist of money market accounts. All cash and cash equivalents are maintained with major financial institutions in North America. Deposits with these financial institutions may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of accounts receivable. The Company’s customers are primarily insulation distributors, insulation contractors, insulation fabricators and select end-users located throughout the world. The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral to secure accounts receivable. The Company maintains an allowance for doubtful accounts based on its assessment of the collectability of accounts receivable. The Company reviews the allowance for doubtful accounts quarterly. During the year ended December 31, 2018, the Company recorded a charge for uncollectible accounts receivable of $2.9 million related to four customers of which one customer accounted for $2.8 million of the charge. Allowance for doubtful accounts was $2.8 and zero at December 31, 2018 and 2017, respectively. The Company does not have any off-balance-sheet credit exposure related to its customers. For the year ended December 31, 2018, one customer represented 20% of total revenue. For the year ended December 31, 2017, two customers represented 15% and 12% of total revenue, respectively. For the year ended December 31, 2016, two customers represented 25% and 15% of total revenue, respectively. At December 31, 2018, the Company had one customer that accounted for 18% of accounts receivable. At December 31, 2017, the Company had three customers that accounted for 19%, 14% and 11% of accounts receivable, respectively.
Inventories	Inventories Inventory consists of finished products and raw materials. Inventories are carried at lower of cost, determined using the first-in, first-out (FIFO) method, and net realizable value. Cost includes materials, labor and manufacturing overhead. Manufacturing overhead is allocated to the costs of conversion based on normal capacity of the Company’s production facility. Abnormal freight, handling costs and material waste is expensed in the period it occurs. The Company periodically reviews its inventories and makes provisions as necessary for estimated excess, obsolete or damaged goods to ensure values approximate the lower of cost and net realizable value. The amount of any such provision is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, selling prices and market conditions.
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net Property, plant and equipment are stated at cost. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property, plant and equipment. Interest expense capitalization commences at the time a capital project begins construction and concludes when the project is completed. The Company has capitalized interest costs as part of the historical costs of constructing its manufacturing facilities or significant capital projects. The Company capitalized less than $0.1 million in interest costs related to the capacity expansion project of the existing East Providence, Rhode Island manufacturing facility during the year ended December 31, 2018. The Company did not capitalize interest on projects during the years ended December 31, 2017 or December 31 2016. Depreciation on plant and equipment is calculated on the straight-line method over the estimated useful lives of the assets. Assets related to leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or estimated useful life of the asset. Assets utilized in the Company’s operations that are taken out of service with no future use are charged to cost of revenue or operating expenses, depending on the department in which the asset was utilized. Impairments of construction in progress are charged to operating expenses upon the determination of no future use.
Other Assets	Other Assets Other assets primarily include long-term deposits.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recognition and measurement of a potential impairment is performed on assets grouped with other assets and liabilities at the lowest level where identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to future undiscounted net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the fair value of the asset or asset group. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. The Company had previously completed the design and engineering for a second manufacturing facility to be located in Statesboro, Georgia supported by a package of incentives, including free land, from state and local governmental authorities. During 2016, the Company elected to delay construction of the facility due to its assessment of future demand. In December 2018, the local governmental authorities notified the Company that they will exercise their right to terminate the incentive package in February 2019 and to make the identified site available to other parties. In addition, the Company determined that due to its cumulative manufacturing process advancements since 2016 and expected additional improvements in the near future, it will not use the existing design and engineering to construct a second facility in any location. Accordingly, the Company determined that the design and engineering costs are not recoverable and recorded an impairment charge of $7.4 million on construction in progress assets during 2018.
Deferred Rent	Deferred Rent For leases that contain fixed increases in the minimum annual lease payment during the original term of the lease, the Company recognizes rental expense on a straight-line basis over the lease term, and records the difference between rent expense and the amount currently payable as deferred rent. Lease incentives for allowances for qualified leasehold improvements received from landlords are amortized on a straight-line basis over the lease term. The short-term portion of deferred rent is included within accrued expenses on the consolidated balance sheet.
Revenue Recognition	Revenue Recognition On January 1, 2018, the Company adopted Accounting Standards Codification 606, Revenue from Contracts with Customers (ASC 606). See note 3 for further details.
Warranty	Warranty The Company provides warranties for its products and records the estimated cost within cost of sales in the period that the related revenue is recorded. The Company’s standard warranty period extends to one year from the date of shipment. This standard warranty provides that the Company’s products will be free from defects in material and workmanship, and will, under normal use, conform to the specifications for the product. The Company’s products may be utilized in systems that involve new technical demands and new configurations. Accordingly, the Company regularly reviews and assesses whether warranty reserves should be recorded in the period the related revenue is recorded. For an initial shipment of product for use in a system with new technical demands or new configurations and where the Company is unsure of meeting the customer’s specifications, the Company will defer the recognition of product revenue and related costs until written customer acceptance is obtained. The Company performs periodic testing of its aerogel blankets to ensure compliance with published performance specifications. From time to time, tests may indicate a product could potentially perform outside of these specifications. At that time, additional testing is initiated or the Company may conduct a root cause investigation. During the year ended December 31, 2018, test results indicated that tested samples performed outside the published performance specifications for a specific attribute of a product. The Company has determined that it is probable it has incurred a liability, however, a liability or range of liability is not estimable as of December 31, 2018. The Company will continue to assess the impact of the testing results on its customer base and, depending on the assessment, could be subject to warranty charges in future periods. The Company did not record any warranty expense during the year ended December 31, 2018. During the years ended December 31, 2017 and 2016, the Company recorded warranty expense of $0.9 million and $0.5 million, respectively. These specific warranty charges were related to product claims for two separate product application issues. These claims were outside of the Company’s typical experience. As of December 31, 2018, the Company had satisfied all outstanding warranty claims.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs are classified as a component of cost of revenue. Customer payments of shipping and handling costs are recorded as product revenue.
Stock-based Compensation	Stock-based Compensation The Company grants share-based awards to its employees and non-employee directors. All share-based awards granted, including grants of stock options, restricted stock and restricted stock units (RSUs), are recognized in the statement of operations based on their fair value as of the date of grant. Expense is recognized on a straight-line basis over the requisite service period for all awards with service conditions. For performance-based awards, the grant date fair value is recognized as expense when the condition is probable of being achieved, and then on a graded basis over the requisite service period. The Company uses the Black-Scholes option-pricing model to determine the fair value of service-based option awards. The Black-Scholes model requires the use of a number of complex and subjective assumptions including fair value of the underlying security, the expected volatility of the underlying security, a risk-free interest rate and the expected term of the option. The fair value of restricted stock and RSUs is determined using the closing price of the Company’s common stock on the date of grant. All shares of restricted stock are not transferable until vested. Restricted stock is typically issued to non-employee directors and typically vests over a one-year period from the date of issuance. RSUs are issued to employees and typically vest over a three to four year period from the date of issuance. The fair value of restricted stock and RSUs upon which vesting is solely service-based is expensed ratably over the vesting period. If the service condition for shares of restricted stock is not met for any reason, the shares of unvested restricted stock will be forfeited and returned to the Company. For stock options that contain a market condition, the Company uses the Monte-Carlo simulation option-pricing model to determine the fair value of the awards. In addition to the input assumptions used in the Black-Scholes model, the Monte-Carlo simulation option-pricing model factors the probability that the specific market condition may or may not be satisfied into the valuation. Stock-based compensation expense for awards with a market condition is recognized on a straight-line basis over the requisite service period for each such award. Pursuant to the evergreen provisions of the 2014 Employee, Director and Consultant Equity Incentive Plan, the number of shares of common stock authorized for issuance under the plan automatically increased by 472,863 shares to 7,009,460 shares effective January 1, 2018.
Research and Development	Research and Development Costs incurred in the research and development of the Company’s products include compensation and related costs, services provided by third-party contractors, materials and supplies and are classified as research and development expenses as incurred. Research and development costs directly associated with research services revenue are classified as research services in cost of revenue.
Earnings per Share	Earnings per Share The Company calculates net loss per common share based on the weighted-average number of common shares outstanding during each period. Potential common stock equivalents are determined using the treasury stock method. The weighted-average number of common shares included in the computation of diluted net income (loss) gives effect to all potentially dilutive common equivalent shares, including outstanding stock options, RSUs and warrants. Common equivalent shares are excluded from the computation of diluted net loss per share if their effect is antidilutive.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. The Company accounts for uncertain tax positions using a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Differences between tax positions taken in a tax return and amounts recognized in the financial statements are recorded as adjustments to income taxes payable or receivable, or adjustments to deferred taxes, or both. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes penalties and interest related to uncertain tax positions, if any, as a component of income tax expense.
Segments	Segments Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker in making decisions on how to allocate resources and assess performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company’s chief operating decision maker reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company. The Company views its operations and manages its business as one operating segment. Information about the Company’s total revenues, based on shipment destination or services location, is presented in the following table: Year Ended December 31, 2018 2017 2016 (In thousands) Revenue: U.S. $ 41,733 $ 51,439 $ 35,726 International 62,628 60,192 82,012 Total revenue $ 104,361 $ 111,631 $ 117,738
Recently Issued Accounting Standards	Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, the Company evaluates the pronouncements to determine the potential effects of adoption to its consolidated financial statements. Standards Implemented After December 31, 2017 In August 2015, the FASB issued a deferral of ASU 2014-09, Revenue from Contracts with Customers. The standard replaced the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP with a principle based approach for determining revenue recognition. As a result of the deferral, public entities were required to apply the revised revenue recognition standard for the annual reporting period beginning on or after December 15, 2017, including interim periods within that annual reporting period. The Company adopted this standard using the modified retrospective method on January 1, 2018. The Company completed its analysis of the new revenue standard and determined that it would not materially impact the allocation and timing of recognition of previously reported revenues from the sale of products or performance of research and development services. In addition, the Company determined that there were no incremental contract costs or contract fulfillment costs to be recognized in connection with the adoption. Based on the Company’s analysis, no adjustment to retained earnings was required as of the January 1, 2018 adoption date. Accordingly, the Company’s application of the standard did not have a material impact on the Company’s consolidated balance sheet at January 1, 2018 and did not have a material impact to its statement of operations for the years ended In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15). This amendment addresses eight classification issues related to the statement of cash flows. The amendments in ASU 2016-15 are effective for public business entities for annual and interim periods in fiscal years beginning after December 15, 2017. The Company adopted the provisions of the amendment on January 1, 2018. The adoption of the standard has not resulted in any material impact to the Company’s consolidated financial statements or other disclosures. Standards to be Implemented After December 31, 2018 In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . FASB ASU 2016-02 modifies the accounting for leases and requires that all leases be recorded on the consolidated balance sheets as assets and liabilities. This standard is effective for fiscal years beginning after December 15, 2018.

Summary of Basis of Presentat_2

Summary of Basis of Presentation and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of Revenues, Based on Shipment Destination or Research Services Location	Information about the Company’s total revenues, based on shipment destination or services location, is presented in the following table: Year Ended December 31, 2018 2017 2016 (In thousands) Revenue: U.S. $ 41,733 $ 51,439 $ 35,726 International 62,628 60,192 82,012 Total revenue $ 104,361 $ 111,631 $ 117,738

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Summary of Revenue Disaggregated by Geographical Region and Source of Revenue	In the following table, revenue is disaggregated by primary geographical region and source of revenue: Year Ended December 31, 2018 U.S. International Total (In thousands) Geographical region Asia $ — $ 34,597 $ 34,597 Canada — 4,749 4,749 Europe — 19,905 19,905 Latin America — 3,377 3,377 U.S. 41,733 — 41,733 Total revenue $ 41,733 $ 62,628 $ 104,361 Source of revenue Product revenue $ 39,490 $ 54,487 $ 93,977 Subsea projects 5 8,141 8,146 Research services 2,238 — 2,238 Total revenue $ 41,733 $ 62,628 $ 104,361
Summary of Changes in Contract Assets and Contract Liabilities	The following table presents changes in the Company’s contract assets and contract liabilities during the year ended December 31, 2018: Balance at December 31, 2017 Additions Deductions Balance at December 31, 2018 (In thousands) Contract assets Subsea projects $ 2,463 $ 8,555 $ (8,276 ) $ 2,742 Research services 425 2,283 (2,339 ) 369 Total contract assets $ 2,888 $ 10,838 $ (10,615 ) $ 3,111 Contract liabilities Deferred revenue Product revenue $ 1,178 $ 1,890 $ (1,317 ) $ 1,751 Subsea projects 126 7,037 (6,382 ) 781 Research services - 180 (83 ) 97 Prepayment liability - 5,000 (515 ) 4,485 Total contract liabilities $ 1,304 $ 14,107 $ (8,297 ) $ 7,114
ASC 606 [Member]
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Schedule of Impacts of Adopting ASC 606 on Components of Consolidated Balance Sheets and Consolidated Statements of Operations	The following tables summarize the impacts of adopting ASC 606 on certain components of the Company’s consolidated financial statements as of and for the year ended Consolidated Balance Sheets As of December 31, 2018 As reported under ASC 606 Pro forma as if ASC 605 was in effect (In thousands) Inventories $ 7,318 $ 10,572 Total current assets 37,251 40,505 Total assets 99,023 102,277 Deferred revenue 2,629 5,759 Total current liabilities 23,066 26,196 Total liabilities 28,769 31,899 Accumulated deficit (471,585 ) (471,461 ) Total stockholders’ equity 70,254 70,378 Total liabilities and stockholders’ equity 99,023 102,277 Consolidated Statements of Operations Year Ended December 31, 2018 As reported under ASC 606 Pro forma as if ASC 605 was in effect (In thousands) Product revenue $ 102,123 $ 98,993 Total revenue 104,361 101,231 Product cost of revenue 90,660 87,406 Gross profit 12,669 12,793 Loss from operations (33,916 ) (33,792 ) Net loss (34,440 ) (34,316 )

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2018
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following: December 31, 2018 2017 (In thousands) Raw material $ 3,159 $ 2,543 Finished goods 4,159 6,372 Total $ 7,318 $ 8,915

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2018
Property Plant And Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consist of the following: December 31, 2018 2017 Useful life (In thousands) Construction in progress $ 1,568 $ 7,699 — Buildings 24,016 24,013 30 years Machinery and equipment 120,466 118,786 3 — 10 years Computer equipment and software 8,352 8,099 3 years Total 154,402 158,597 Accumulated depreciation and amortization (92,703 ) (82,530 ) Property, plant and equipment, net $ 61,699 $ 76,067

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2018
Payables And Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consist of the following: December 31, 2018 2017 (In thousands) Employee compensation $ 2,750 $ 4,633 Other accrued expenses 1,114 1,229 Total $ 3,864 $ 5,862

Deferred Rent (Tables)

Deferred Rent (Tables)	12 Months Ended
	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Summary of Deferred Rent	Deferred rent consists of the following: December 31, 2018 2017 (In thousands) Deferred rent $ 1,368 $ 1,511 Current maturities of deferred rent (150 ) (208 ) Deferred rent, less current maturities $ 1,218 $ 1,303

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
Summary of Future Minimum Lease Payments Under Operating Leases	Future minimum lease payments under operating leases at December 31, 2018 are as follows: Year Operating Leases (In thousands) 2019 $ 1,375 2020 1,304 2021 1,124 2022 1,068 2023 1,082 Thereafter 1,701 Total minimum lease payments $ 7,654

Employee Stock Ownership Plans

Employee Stock Ownership Plans (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Stock Based Compensation Included in Cost of Sales or Operating Expenses	Stock-based compensation is included in cost of sales or operating expenses, as applicable, and consists of the following: Year Ended December 31, 2018 2017 2016 (In thousands) Cost of product revenue $ 577 $ 790 $ 796 Research and development expenses 461 555 594 Sales and marketing expenses 815 1,096 1,066 General and administrative expenses 2,449 2,650 2,857 Total stock-based compensation $ 4,302 $ 5,091 $ 5,313
Summary of Fair Value of Option Awards Estimated by Use of Black-Scholes Option Pricing Model	The following information relates to the fair value of the option awards estimated by use of the Black-Scholes option pricing model: Year Ended December 31, 2018 2017 2016 (In thousands) Weighted average assumptions: Expected term (in years) 5.93 5.86 5.86 Expected volatility 47.68 % 51.95 % 53.56 % Risk free rate 2.76 % 1.99 % 1.36 % Expected dividend yield 0.00 % 0.00 % 0.00 % Weighted average fair value: Grant-date fair value of options granted $ 2.29 $ 2.08 $ 2.16 Grant-date fair value of options vested $ 3.29 $ 3.98 $ 7.58 Aggregate intrinsic value of options exercised $ — $ — $ —
Summary of Stock Option Outstanding	The following table summarizes information about stock options outstanding: Number of Shares Weighted Average Grant Date Fair Value Per Share Weighted Average Exercise Price Per Share Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value ($ in thousands, except share and per share data) Options outstanding at December 31, 2017 2,432,906 $ 7.18 $ 10.48 7.64 $ 554,236 Granted 574,256 $ 2.29 $ 4.73 Forfeited (12,710 ) $ 11.65 $ 16.07 Exercised — $ — $ — $ — Options outstanding at December 31, 2018 2,994,452 $ 6.22 $ 9.34 7.11 $ — Exercisable at December 31, 2018 1,743,482 $ 8.87 $ 12.40 6.32 $ — Expected to vest at December 31, 2018 1,250,970 $ 2.53 $ 5.08 8.22 $ —
Summary of Grants of RSUs	Information related to grants of RSUs during 2018 is as follows: Restricted Stock Units Weighted Average Grant Date Fair Value Balance at December 31, 2017 827,391 $ 4.59 Granted 497,910 4.62 Vested (391,989 ) 5.13 Forfeited (58,085 ) 4.31 Balance at December 31, 2018 875,227 $ 4.38

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Loss Per Share	The computation of basic and diluted net loss per share consists of the following: Year ended December 31, 2018 2017 2016 (In thousands, except share and per share data) Numerator: Net loss $ (34,440 ) $ (19,321 ) $ (12,023 ) Denominator: Weighted average shares outstanding, basic and diluted 23,738,852 23,390,235 23,139,807 Net loss per share, basic and diluted $ (1.45 ) $ (0.83 ) $ (0.52 )
Summary of Potentially Dilutive Common Shares Excluded from Computation of Diluted Net Loss Per Share	Potentially dilutive common shares that were excluded from the computation of diluted net loss per share because they were anti-dilutive consist of the following: Year ended December 31, 2018 2017 2016 Common stock options 2,994,452 2,432,906 2,063,574 Restricted common stock units 875,227 827,391 682,085 Common stock warrants — — 115 Restricted common stock awards 136,187 151,859 153,277 Total 4,005,866 3,412,156 2,899,051

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Schedule of Reconciliation Between U.S. Statutory Income Tax Rate and Company's Effective Rate	The reconciliation between the U.S. statutory income tax rate and the Company’s effective rate consists of the following: Year Ended December 31, 2018 2017 2016 U.S. federal income tax statutory rate 21 % 35 % 35 % Permanent differences — % (3 )% (4 )% State tax, net of federal benefit 2 % (5 )% (1 )% Changes in valuation allowance for deferred tax assets (22 )% 113 % (30 )% Stock-based compensation — % — % (1 )% 2017 Tax Cuts and Jobs Act — % (138 )% — % Other (1 )% (2 )% 1 % Effective tax rate — — —
Schedule of Deferred Tax Assets and Deferred Tax Liabilities	The tax effects of temporary differences between financial statement and tax accounting that gave rise to significant portions of the Company’s deferred tax assets and deferred tax liabilities at December 31, 2018 and 2017 are presented below: December 31, 2018 2017 (In thousands) Deferred tax assets: Net operating loss carryforwards $ 51,629 $ 45,307 Stock-based compensation 5,194 4,719 Tax credit carryforwards 296 308 Reserves and accruals 1,258 492 Interest expense limitation 135 — Intangible assets and amortization 50 56 Total gross deferred tax assets 58,562 50,882 Deferred tax liabilities: Depreciation (4,614 ) (4,645 ) Total deferred tax liabilities (4,614 ) (4,645 ) Total deferred tax assets and liabilities 53,948 46,237 Valuation allowance (53,948 ) (46,237 ) Net deferred tax asset $ — $ —

Quarterly Results of Operatio_2

Quarterly Results of Operations (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Summary of Quarterly Financial Information	QUARTERLY RESULTS OF OPERATIONS Three Months Ended March 31, June 30, Sept 30, Dec 31, (in thousands, except per share data) (unaudited) 2018 Total revenue $ 23,074 $ 21,671 $ 23,937 $ 35,679 Gross profit 2,810 2,744 1,529 5,586 Loss from operations (6,750 ) (6,855 ) (6,369 ) (13,942 ) Net loss (6,842 ) (6,958 ) (6,532 ) (14,108 ) Net loss per share basic and diluted common share - basic $ (0.29 ) $ (0.29 ) $ (0.27 ) $ (0.59 ) 2017 Total revenue $ 23,002 $ 25,069 $ 27,198 $ 36,362 Gross profit 2,221 3,694 4,948 7,808 Loss from operations (9,052 ) (5,433 ) (3,030 ) (1,621 ) Net loss (9,078 ) (5,472 ) (3,088 ) (1,683 ) Net income loss per share basic and diluted common share - basic $ (0.39 ) $ (0.23 ) $ (0.13 ) $ (0.07 )

Description of Business - Addit

Description of Business - Additional Information (Detail) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017USD ($)	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018USD ($)Subsidiary	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Basis Of Presentation [Line Items]
Number of Subsidiaries | Subsidiary									3
Net loss incurred	$ 14,108	$ 6,532	$ 6,958	$ 6,842	$ 1,683	$ 3,088	$ 5,472	$ 9,078	$ 34,440	$ 19,321	$ 12,023
Cash used in operations									8,654	4,606	$ 578
Cash and cash equivalents	3,327				10,694				3,327	10,694
Outstanding borrowings under revolving line of credit	4,181				$ 3,750				4,181	$ 3,750
Revolving Credit Facility [Member]
Basis Of Presentation [Line Items]
Outstanding borrowings under revolving line of credit	4,200								4,200
Additional amount available under revolving line of credit	$ 10,300								$ 10,300
Existing maturity date									Apr. 28, 2020

Summary of Basis of Presentat_3

Summary of Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)	Jan. 02, 2017shares	Dec. 11, 2015	Dec. 31, 2018USD ($)CustomerSegmentshares	Dec. 31, 2017USD ($)Customer	Dec. 31, 2016USD ($)Customer	Jan. 01, 2017shares
Summary Of Significant Accounting Policies [Line Items]
Charge for uncollectible accounts receivable			$ 2,922,000	$ 455,000
Allowance for doubtful accounts			2,800,000		$ 0
Plant and equipment under capital leases			0
Impairment charge			$ 7,356,000
Standard product warranty period			1 year
Warranty expense			$ 0	900,000	500,000
Number of segment | Segment			1
Deferred rent			$ 1,368,000	1,511,000
ASU 2016-02 [Member}
Summary Of Significant Accounting Policies [Line Items]
Deferred rent			1,400,000
Operating lease liabilities			6,000,000
ROU assets			$ 4,600,000
2014 Equity Plan [Member]
Summary Of Significant Accounting Policies [Line Items]
Increased number of shares authorized for grant | shares			1,815,982
2014 Equity Plan [Member] | Restricted Stock Units [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			3 years
2014 Equity Plan [Member] | Non-Employee Directors [Member] | Restricted Common Stock [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			1 year
2014 Employee Director and Consultant Equity Incentive Plan [Member]
Summary Of Significant Accounting Policies [Line Items]
Authorized for issuance, number of shares increased by | shares	472,863
Increased number of shares authorized for grant | shares						7,009,460
Rhode Island [Member]
Summary Of Significant Accounting Policies [Line Items]
Plant and equipment under capital leases				$ 0	$ 0
Statesboro, Georgia [Member] | Construction in Progress [Member]
Summary Of Significant Accounting Policies [Line Items]
Impairment charge			$ 7,400,000
Maximum [Member] | Restricted Stock Units [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			4 years
Maximum [Member] | 2014 Equity Plan [Member] | Restricted Stock Units [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			4 years
Maximum [Member] | Rhode Island [Member]
Summary Of Significant Accounting Policies [Line Items]
Plant and equipment under capital leases			$ 100,000
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period		3 years
Minimum [Member] | Restricted Stock Units [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			3 years
Minimum [Member] | 2014 Equity Plan [Member] | Restricted Stock Units [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based award vesting period			3 years
Total Revenue [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of customers | Customer			1	2	2
Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of customers | Customer			1	3
Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of customers with charge for uncollectible accounts receivable | Customer			4
Customer One [Member] | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Charge for uncollectible accounts receivable			$ 2,800,000
Customer One [Member] | Customer Concentration Risk [Member] | Total Revenue [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			20.00%	15.00%	25.00%
Customer One [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			18.00%	19.00%
Customer Two [Member] | Customer Concentration Risk [Member] | Total Revenue [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage				12.00%	15.00%
Customer Two [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage				14.00%
Customers Three [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage				11.00%

Summary of Basis of Presentat_4

Summary of Basis of Presentation and Significant Accounting Policies - Schedule of Revenues, Based on Shipment Destination or Research Services Location (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Total revenue	$ 35,679	$ 23,937	$ 21,671	$ 23,074	$ 36,362	$ 27,198	$ 25,069	$ 23,002	$ 104,361	$ 111,631	$ 117,738
U.S. [Member]
Segment Reporting Information [Line Items]
Total revenue									41,733	51,439	35,726
International [Member]
Segment Reporting Information [Line Items]
Total revenue									$ 62,628	$ 60,192	$ 82,012

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Additional Information (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017USD ($)	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018USD ($)Agreement	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Revenue Recognition [Line Items]
Revenue	$ 35,679	$ 23,937	$ 21,671	$ 23,074	$ 36,362	$ 27,198	$ 25,069	$ 23,002	$ 104,361	$ 111,631	$ 117,738
Deferred revenue, revenue recognized									1,300
Total assets	99,023				123,815				99,023	123,815
Total liabilities	28,769				22,872				28,769	22,872
ASC 606 [Member] | Difference between Revenue Guidance in Effect Before and After Topic 606 [Member]
Revenue Recognition [Line Items]
Total assets	3,300								3,300
Total liabilities	3,100								3,100
Maximum [Member]
Revenue Recognition [Line Items]
Sales return reserves	$ 100				$ 100				$ 100	100
Product Revenue [Member]
Revenue Recognition [Line Items]
Number of peformance obligations | Agreement									1
Revenue									$ 93,977
Subsea Projects [Member]
Revenue Recognition [Line Items]
Revenue									$ 8,146
Research Services [Member]
Revenue Recognition [Line Items]
Number of peformance obligations | Agreement									1
Revenue									$ 2,238
Product [Member]
Revenue Recognition [Line Items]
Revenue									102,123	109,590	115,490
Product cost of revenue									90,660	$ 92,052	$ 93,123
Product [Member] | ASC 606 [Member] | Difference between Revenue Guidance in Effect Before and After Topic 606 [Member]
Revenue Recognition [Line Items]
Revenue									3,100
Product cost of revenue									$ 3,300

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Summary of Revenue Disaggregated by Geographical Region and Source of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disaggregation Of Revenue [Line Items]
Total revenue	$ 35,679	$ 23,937	$ 21,671	$ 23,074	$ 36,362	$ 27,198	$ 25,069	$ 23,002	$ 104,361	$ 111,631	$ 117,738
Product Revenue [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									93,977
Subsea Projects [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									8,146
Research Services [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									2,238
Asia [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									34,597
Canada [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									4,749
Europe [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									19,905
Latin America [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									3,377
U.S. [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									41,733
U.S. [Member] | Product Revenue [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									39,490
U.S. [Member] | Subsea Projects [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									5
U.S. [Member] | Research Services [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									2,238
International [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									62,628
International [Member] | Product Revenue [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									54,487
International [Member] | Subsea Projects [Member]
Disaggregation Of Revenue [Line Items]
Total revenue									$ 8,141

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Summary of Changes in Contract Assets and Contract Liabilities (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Contract assets
Beginning Balance	$ 2,888
Additions	10,838
Deductions	(10,615)
Ending Balance	3,111
Contract liabilities
Beginning Balance	1,304
Additions	14,107
Deductions	(8,297)
Ending Balance	7,114
Subsea Projects [Member]
Contract assets
Beginning Balance	2,463
Additions	8,555
Deductions	(8,276)
Ending Balance	2,742
Contract liabilities
Beginning Balance	126
Additions	7,037
Deductions	(6,382)
Ending Balance	781
Research Services [Member]
Contract assets
Beginning Balance	425
Additions	2,283
Deductions	(2,339)
Ending Balance	369
Contract liabilities
Additions	180
Deductions	(83)
Ending Balance	97
Product Revenue [Member]
Contract liabilities
Beginning Balance	1,178
Additions	1,890
Deductions	(1,317)
Ending Balance	1,751
Prepayment Liability [Member]
Contract liabilities
Additions	5,000
Deductions	(515)
Ending Balance	$ 4,485

Revenue from Contracts with C_6

Revenue from Contracts with Customers - Schedule of Impacts of Adopting ASC 606 on Components of Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	$ 7,318	$ 8,915
Total current assets	37,251	47,662
Total assets	99,023	123,815
Deferred revenue	2,629	1,304
Total current liabilities	23,066	21,569
Total liabilities	28,769	22,872
Accumulated deficit	(471,585)	(437,145)
Total stockholders’ equity	70,254	100,943	$ 115,564	$ 122,474
Total liabilities and stockholders’ equity	99,023	$ 123,815
ASC 606 [Member] | Pro forma as if ASC 605 was in Effect [Member]
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	10,572
Total current assets	40,505
Total assets	102,277
Deferred revenue	5,759
Total current liabilities	26,196
Total liabilities	31,899
Accumulated deficit	(471,461)
Total stockholders’ equity	70,378
Total liabilities and stockholders’ equity	$ 102,277

Revenue from Contracts with C_7

Revenue from Contracts with Customers - Schedule of Impacts of Adopting ASC 606 on Components of Consolidated Statements of Operations (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Total revenue	$ 35,679	$ 23,937	$ 21,671	$ 23,074	$ 36,362	$ 27,198	$ 25,069	$ 23,002	$ 104,361	$ 111,631	$ 117,738
Gross profit	5,586	1,529	2,744	2,810	7,808	4,948	3,694	2,221	12,669	18,671	23,311
Loss from operations	(13,942)	(6,369)	(6,855)	(6,750)	(1,621)	(3,030)	(5,433)	(9,052)	(33,916)	(19,136)	(11,220)
Net loss	$ (14,108)	$ (6,532)	$ (6,958)	$ (6,842)	$ (1,683)	$ (3,088)	$ (5,472)	$ (9,078)	(34,440)	(19,321)	(12,023)
ASC 606 [Member] | Pro forma as if ASC 605 was in Effect [Member]
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Total revenue									101,231
Gross profit									12,793
Loss from operations									(33,792)
Net loss									(34,316)
Product [Member]
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Total revenue									102,123	109,590	115,490
Product cost of revenue									90,660	$ 92,052	$ 93,123
Product [Member] | ASC 606 [Member] | Pro forma as if ASC 605 was in Effect [Member]
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Total revenue									98,993
Product cost of revenue									$ 87,406

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Raw material	$ 3,159	$ 2,543
Finished goods	4,159	6,372
Total	$ 7,318	$ 8,915

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 154,402	$ 158,597
Accumulated depreciation and amortization	(92,703)	(82,530)
Property, plant and equipment, net	61,699	76,067
Construction in Progress [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,568	7,699
Buildings [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 24,016	24,013
Property, plant and equipment, Useful life	30 years
Machinery and Equipment [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 120,466	118,786
Machinery and Equipment [Member] | Minimum [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, Useful life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, Useful life	10 years
Computer Equipment and Software [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 8,352	$ 8,099
Property, plant and equipment, Useful life	3 years

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Property Plant and Equipment [Line Items]
Depreciation expense	$ 10,800,000	$ 10,800,000	$ 9,800,000
Assets under capital leases	0
Property, plant and equipment, gross	154,402,000	158,597,000
Impairment charge	7,356,000
Construction in Progress [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,568,000	7,699,000
Statesboro, Georgia [Member] | Construction in Progress [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross		7,200,000
Impairment charge	7,400,000
Rhode Island [Member]
Property Plant and Equipment [Line Items]
Assets under capital leases		0	0
Rhode Island [Member] | Construction in Progress [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,200,000
Maximum [Member]
Property Plant and Equipment [Line Items]
Capital leases, amortization expense		100,000	$ 100,000
Maximum [Member] | Rhode Island [Member]
Property Plant and Equipment [Line Items]
Assets under capital leases	$ 100,000
Maximum [Member] | Rhode Island [Member] | Construction in Progress [Member]
Property Plant and Equipment [Line Items]
Property, plant and equipment, gross		$ 100,000

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accrued Liabilities Current [Abstract]
Employee compensation	$ 2,750	$ 4,633
Other accrued expenses	1,114	1,229
Total	$ 3,864	$ 5,862

Revolving Line of Credit - Addi

Revolving Line of Credit - Additional Information (Detail) - USD ($)	Mar. 04, 2019	Jan. 30, 2019	Apr. 25, 2018	Jan. 25, 2018	Dec. 31, 2018	Dec. 31, 2017
Line of Credit Facility [Line Items]
Line of credit facility amount withdrawn					$ 4,181,000	$ 3,750,000
Borrowed under line of credit					56,716,000	27,250,000
Repaid under line of credit					56,285,000	23,500,000
Prepayment amount received					5,000,000
Revolving line of credit					$ 4,181,000	3,750,000
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Extended maturity date					Apr. 28, 2020
Line of credit facility amount withdrawn					$ 4,200,000
Available borrowing capacity					10,300,000
Revolving line of credit					$ 4,200,000
Silicon Valley Bank Credit Facility [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Interest rate description					The interest rate applicable to borrowings under the revolving credit facility may be based on the prime rate or LIBOR. Prime rate-based rates vary from prime rate plus 0.75% per annum to prime rate plus 2.00% per annum, while LIBOR-based rates vary from LIBOR plus 3.75% per annum to LIBOR plus 4.25% per annum.
Silicon Valley Bank Credit Facility [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Extended maturity date	Apr. 28, 2020
Maximum increased borrowing amount	$ 20,000,000
Percentage of unused line fee	0.50%
Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member]
Line of Credit Facility [Line Items]
Maximum increased borrowing amount				$ 20,000,000
Interest rate description					The interest rate applicable to borrowings may be based on the prime rate or LIBOR. Prime rate-based rates vary from prime rate plus 0.75%?per annum to prime rate plus 1.75%?per annum, while LIBOR-based rates vary from LIBOR plus 3.75% per annum to LIBOR plus 4.25% per annum.
Percentage of unused line fee				0.50%
Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Extended maturity date			Apr. 28, 2019	Apr. 28, 2018
Line of credit facility amount withdrawn					$ 4,200,000	3,800,000
Borrowed under line of credit					56,700,000
Repaid under line of credit					56,300,000
Issuance of equity					3,250,000
Customer advanced payments					5,000,000
Letters of credit outstanding					1,600,000	2,300,000
Available borrowing capacity					10,300,000
Revolving line of credit					$ 4,200,000	$ 3,800,000
Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Revolving Credit Facility [Member] | BASF [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Prepayment amount received		$ 5,000,000
Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Minimum [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum	0.75%
Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Maximum [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum	2.00%
Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum				0.75%
Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum				2.00%
LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Minimum [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum	3.75%
LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Maximum [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum	4.25%
LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum				3.75%
LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Loan Agreement [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Additional interest rate per annum				4.25%

Other Expense, Net - Additional

Other Expense, Net - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Non Operating Income Expense [Line Items]
Other expense, net	$ 500	$ 200	$ 800
Financing and debt issuance costs			700
Interest expense	$ (524)	$ (185)	(147)
Silicon Valley Bank Credit Facility [Member]
Other Non Operating Income Expense [Line Items]
Interest expense			$ (100)

Deferred Rent - Summary of Defe

Deferred Rent - Summary of Deferred Rent (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Deferred Revenue And Credits [Abstract]
Deferred rent	$ 1,368	$ 1,511
Current maturities of deferred rent	(150)	(208)
Deferred rent, less current maturities	$ 1,218	$ 1,303

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)ft²
Commitments And Contingencies [Line Items]
Lease annual base rent	$ 1,500,000	$ 1,400,000	$ 1,500,000
Leasehold improvement costs capitalized	1,200,000	1,200,000
Prepayment proceeds under customer supply agreement, net	5,000,000
Silicon Valley Bank Credit Facility [Member] | Revolving Credit Facility [Member]
Commitments And Contingencies [Line Items]
Letters of credit outstanding	$ 1,600,000	2,300,000
Landlord [Member] | Lease Agreement [Member]
Commitments And Contingencies [Line Items]
Number of square feet for lease | ft²			51,650
Lease end date			Dec. 31, 2026
Lease commence date			Jan. 1, 2017
Lease annual base rent		$ 408,000
Lease increased percentage		3.00%
Lease extended term			3 years
Amount receivables as an aid to construction of improvements of the leased premise			$ 1,200,000
BASF [Member] | Supply and Joint Development Agreement Amended [Member]
Commitments And Contingencies [Line Items]
Supply agreement termination date	Dec. 31, 2027
Prepayment liability	$ 5,000,000
Prepayment proceeds under customer supply agreement, net	5,000,000
Prepayment liability, net of current portion	500,000
BASF [Member] | Supply and Joint Development Agreement Amended [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Non-interest bearing prepayments, aggregate amount	$ 22,000,000
Credit limit percentage on prepayment balance	25.30%

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Future Minimum Payments Under Operating Leases (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Commitments And Contingencies Disclosure [Abstract]
2,019	$ 1,375
2,020	1,304
2,021	1,124
2,022	1,068
2,023	1,082
Thereafter	1,701
Total minimum lease payments	$ 7,654

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - shares	Dec. 31, 2018	Dec. 31, 2017
Equity [Abstract]
Total number of shares authorized	130,000,000	130,000,000
Common stock, shares authorized	125,000,000	125,000,000
Preferred stock, shares authorized	5,000,000	5,000,000

Employee Benefit Plan - Additio

Employee Benefit Plan - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]
Matching contribution during the period	$ 0.2	$ 0.2	$ 0.2

Employee Stock Ownership Plan_2

Employee Stock Ownership Plans - Additional Information (Detail) - USD ($) $ in Millions	Nov. 07, 2018	Aug. 02, 2017	Dec. 11, 2015	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jan. 01, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based awards granted to purchase common stock				574,256
Aggregate value of restricted stock issuance			$ 2
Number of comparable companies for expected volatility				the Company’s uses an estimated volatility based on the historical volatility of comparable companies with publicly available share prices. In 2018, 2017 and 2016, the expected volatility is based on the weighted average volatility of up to 17 companies with business, financial and market attributes that the Company believes are similar to its own.
Expected dividend yield				0.00%	0.00%	0.00%
ASU 2016-09 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative effect adjustment to equity								$ 0.3
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock awards modified during the period		78,125
2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance				3,780,217
Increased number of shares available for future grant				1,815,982
2001 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance				89,465
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested options grants				$ 2.3
Unrecognized compensation cost period for recognition				1 year 9 months 18 days
Shares outstanding				875,227	827,391
Total shares vested				391,989
Restricted Stock Units [Member] | Non-Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				1 year
Restricted Stock Units [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issue of stock-based awards			78,125
Restricted Stock Units [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				3 years
Stock-based awards granted				497,910
Stock-based award fair value				$ 2.3
Restricted Stock Units [Member] | 2014 Equity Plan [Member] | Non-Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				1 year
Stock-based awards granted				58,062
Stock-based award fair value				$ 0.3
Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding				136,187
Restricted Common Stock [Member] | 2014 Equity Plan [Member] | Non-Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				1 year
Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based awards granted to purchase common stock			84,745
Total incremental compensation expense	$ 0.1	$ 0.1
Non-Qualified Stock Options [Member] | Common Stock Price Target Achievements Conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based awards granted to purchase common stock			370,181
Non-Qualified Stock Options [Member] | Common Stock Price Target Achievements Conditions, Vesting Four Year Period [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period		4 years
Number of options with modified vesting term		131,578
Non-Qualified Stock Options [Member] | Common Stock Price Target Achievements Conditions, Vesting Five Year Period [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period		5 years
Number of options with modified vesting term		122,324
Non-Qualified Stock Options [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				3 years
Stock-based award fair value				$ 1.1
Non-Qualified Stock Options [Member] | 2014 Equity Plan [Member] | Non-Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				1 year
Stock-based award fair value				$ 0.4
Service Based Awards [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested options grants				$ 1.7
Unrecognized compensation cost period for recognition				1 year 9 months
Restricted Stock and Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding				933,289
Total intrinsic value					$ 0.8		$ 1.4
Total shares vested				78,125
Share based compensation recorded in conjunction with award				$ 0.2
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested options grants				$ 0.1
Unrecognized compensation cost period for recognition				5 months 12 days
Performance Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested options grants				$ 0.1
Unrecognized compensation cost period for recognition				2 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period			3 years
Minimum [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				3 years
Minimum [Member] | Restricted Stock Units [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				3 years
Minimum [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period			3 years
Minimum [Member] | Service Based Awards [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				3 years
Maximum [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				4 years
Maximum [Member] | Restricted Stock Units [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				4 years
Maximum [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period			5 years
Maximum [Member] | Service Based Awards [Member] | 2014 Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based award vesting period				4 years

Employee Stock Ownership Plan_3

Employee Stock Ownership Plans - Summary of Stock Based Compensation Included in Cost of Sales or Operating Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	$ 4,302	$ 5,091	$ 5,313
Cost of Product Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	577	790	796
Research and Development Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	461	555	594
Sales and Marketing Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	815	1,096	1,066
General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	$ 2,449	$ 2,650	$ 2,857

Employee Stock Ownership Plan_4

Employee Stock Ownership Plans - Summary of Fair Value of Option Awards Estimated by Use of Black-Scholes Option Pricing Model (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Weighted average assumptions:
Expected term (in years)	5 years 11 months 4 days	5 years 10 months 9 days	5 years 10 months 9 days
Expected volatility	47.68%	51.95%	53.56%
Risk free rate	2.76%	1.99%	1.36%
Expected dividend yield	0.00%	0.00%	0.00%
Weighted average fair value:
Grant-date fair value of options granted	$ 2.29	$ 2.08	$ 2.16
Grant-date fair value of options vested	$ 3.29	$ 3.98	$ 7.58

Employee Stock Ownership Plan_5

Employee Stock Ownership Plans - Summary of Stock Option Outstanding (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of Shares, Beginning Balance	2,432,906
Number of Shares, Granted	574,256
Number of Shares, Forfeited	(12,710)
Number of Shares, Ending Balance	2,994,452	2,432,906
Number of Shares, Exercisable at December 31, 2018	1,743,482
Number of Shares, Expected to vest at December 31, 2018	1,250,970
Weighted Average Grant Date Fair Value Per Share, Beginning Balance	$ 7.18
Weighted Average Grant Date Fair Value Per Share, Granted	2.29	$ 2.08	$ 2.16
Weighted Average Grant Date Fair Value Per Share, Forfeited	11.65
Weighted Average Grant Date Fair Value Per Share, Ending Balance	6.22	7.18
Weighted Average Grant Date Fair Value Per Share, Exercisable at December 31, 2018	8.87
Weighted Average Grant Date Fair Value Per Share, Expected to vest at December 31, 2018	2.53
Weighted Average Exercise Price Per Share, Beginning Balance	10.48
Weighted Average Exercise Price Per Share, Granted	4.73
Weighted Average Exercise Price Per Share, Forfeited	16.07
Weighted Average Exercise Price Per Share, Ending Balance	9.34	$ 10.48
Weighted Average Exercise Price Per Share, Exercisable at December 31, 2018	12.40
Weighted Average Exercise Price Per Share, Expected to vest at December 31, 2018	$ 5.08
Weighted Average Remaining Contractual Term, Outstanding	7 years 1 month 9 days	7 years 7 months 20 days
Weighted Average Remaining Contractual Term, Exercisable at December 31, 2018	6 years 3 months 25 days
Weighted Average Remaining Contractual Term, Expected to vest at December 31, 2018	8 years 2 months 19 days
Aggregate Intrinsic Value, Beginning Balance	$ 554,236
Aggregate Intrinsic Value, Ending Balance		$ 554,236

Employee Stock Ownership Plan_6

Employee Stock Ownership Plans - Summary of Grants of RSUs (Detail) - Restricted Stock Units [Member]	12 Months Ended
	Dec. 31, 2018$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units, Beginning Balance | shares	827,391
Restricted Stock Units, Granted | shares	497,910
Restricted Stock Units, Vested | shares	(391,989)
Restricted Stock Units, Forfeited | shares	(58,085)
Restricted Stock Units, Ending Balance | shares	875,227
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares	$ 4.59
Weighted Average Grant Date Fair Value, Granted | $ / shares	4.62
Weighted Average Grant Date Fair Value, Vested | $ / shares	5.13
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	4.31
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 4.38

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Numerator:
Net loss	$ (14,108)	$ (6,532)	$ (6,958)	$ (6,842)	$ (1,683)	$ (3,088)	$ (5,472)	$ (9,078)	$ (34,440)	$ (19,321)	$ (12,023)
Denominator:
Weighted average shares outstanding, basic and diluted									23,738,852	23,390,235	23,139,807
Net income (loss) per share basic and diluted common share - basic	$ (0.59)	$ (0.27)	$ (0.29)	$ (0.29)	$ (0.07)	$ (0.13)	$ (0.23)	$ (0.39)	$ (1.45)	$ (0.83)	$ (0.52)

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Potentially Dilutive Common Shares Excluded from Computation of Diluted Net Loss Per Share (Detail) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	4,005,866	3,412,156	2,899,051
Common Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	2,994,452	2,432,906	2,063,574
Restricted Common Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	875,227	827,391	682,085
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities			115
Restricted Common Stock Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	136,187	151,859	153,277

Income Taxes - Schedule of Reco

Income Taxes - Schedule of Reconciliation Between U.S. Statutory Income Tax Rate and Company's Effective Rate (Detail)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
U.S. federal income tax statutory rate	21.00%	35.00%	35.00%
Permanent differences		(3.00%)	(4.00%)
State tax, net of federal benefit	2.00%	(5.00%)	(1.00%)
Changes in valuation allowance for deferred tax assets	(22.00%)	113.00%	(30.00%)
Stock-based compensation			(1.00%)
2017 Tax Cuts and Jobs Act		(138.00%)
Other	(1.00%)	(2.00%)	1.00%
Effective tax rate	0.00%	0.00%	0.00%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Deferred Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Deferred tax assets:
Net operating loss carryforwards	$ 51,629	$ 45,307
Stock-based compensation	5,194	4,719
Tax credit carryforwards	296	308
Reserves and accruals	1,258	492
Interest expense limitation	135
Intangible assets and amortization	50	56
Total gross deferred tax assets	58,562	50,882
Deferred tax liabilities:
Depreciation	(4,614)	(4,645)
Total deferred tax liabilities	(4,614)	(4,645)
Total deferred tax assets and liabilities	53,948	46,237
Valuation allowance	(53,948)	(46,237)
Net deferred tax asset	$ 0	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Line Items]
U.S. corporate tax rate	21.00%	35.00%	35.00%
Decrease in net deferred tax asset and corresponding valuation allowance	$ 26,700,000
Net operating losses to maximum offset percentage of future taxable income	80.00%
Net change in valuation allowance	$ 7,700,000
Net operating losses available to offset future state taxable income expiration description	between 2019 and 2038
Unrecognized tax benefits	$ 0	$ 0	$ 0
Interest and penalties related to unrecognized tax benefits	0	0	0
Expected amount of unrecognized tax benefits	0	$ 0	$ 0
Federal [Member]
Income Taxes [Line Items]
Net operating loss carryforwards	223,100,000
Expiration of federal net operating loss carryforwards	$ 194,600,000
Net operating loss carryforwards expiration date	Dec. 31, 2037
Federal [Member] | Unlimited Carryforward [Member]
Income Taxes [Line Items]
Net operating loss carryforwards	$ 28,500,000
State and Local Jurisdiction [Member]
Income Taxes [Line Items]
Net operating loss carryforwards	$ 82,100,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($)	Mar. 04, 2019	Jan. 14, 2019	Jan. 31, 2019	Dec. 31, 2018
Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Extended maturity date				Apr. 28, 2020
Silicon Valley Bank Credit Facility [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Interest rate description				The interest rate applicable to borrowings under the revolving credit facility may be based on the prime rate or LIBOR. Prime rate-based rates vary from prime rate plus 0.75% per annum to prime rate plus 2.00% per annum, while LIBOR-based rates vary from LIBOR plus 3.75% per annum to LIBOR plus 4.25% per annum.
Credit facility, covenant terms				The credit facility has also been amended to (i) revise the definition of “Borrowing Base” to remove the eligible inventory component of the Borrowing Base, (ii) remove the Adjusted Quick Ratio financial covenant set forth in the loan agreement and (iii) establish certain minimum Adjusted EBITDA levels with respect to the minimum Adjusted EBITDA financial covenant for the extended term.
Subsequent Event [Member] | Silicon Valley Bank Credit Facility [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Extended maturity date	Apr. 28, 2020
Maximum increased borrowing amount	$ 20,000,000
Percentage of unused line fee	0.50%
Subsequent Event [Member] | Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Minimum [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Additional interest rate per annum	0.75%
Subsequent Event [Member] | Prime Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Maximum [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Additional interest rate per annum	2.00%
Subsequent Event [Member] | LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Minimum [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Additional interest rate per annum	3.75%
Subsequent Event [Member] | LIBOR Rate [Member] | Silicon Valley Bank Credit Facility [Member] | Maximum [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Additional interest rate per annum	4.25%
Subsequent Event [Member] | Supply and Joint Development Agreement Addendum [Member] | BASF [Member]
Subsequent Event [Line Items]
Non-interest bearing prepayment, remaining aggregate amount remitted			$ 5,000,000
Subsequent Event [Member] | Supply and Joint Development Agreement Addendum [Member] | BASF [Member] | After January 1, 2020 [Member]
Subsequent Event [Line Items]
Credit limit percentage on prepayment balance		50.00%
Subsequent Event [Member] | Supply and Joint Development Agreement Addendum [Member] | BASF [Member] | After December 31, 2022 [Member]
Subsequent Event [Line Items]
Credit limit percentage on prepayment balance		24.70%

Quarterly Results of Operatio_3

Quarterly Results of Operations - Summary of Quarterly Financial Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Total revenue	$ 35,679	$ 23,937	$ 21,671	$ 23,074	$ 36,362	$ 27,198	$ 25,069	$ 23,002	$ 104,361	$ 111,631	$ 117,738
Gross profit	5,586	1,529	2,744	2,810	7,808	4,948	3,694	2,221	12,669	18,671	23,311
Loss from operations	(13,942)	(6,369)	(6,855)	(6,750)	(1,621)	(3,030)	(5,433)	(9,052)	(33,916)	(19,136)	(11,220)
Net loss	$ (14,108)	$ (6,532)	$ (6,958)	$ (6,842)	$ (1,683)	$ (3,088)	$ (5,472)	$ (9,078)	$ (34,440)	$ (19,321)	$ (12,023)
Net income (loss) per share basic and diluted common share - basic	$ (0.59)	$ (0.27)	$ (0.29)	$ (0.29)	$ (0.07)	$ (0.13)	$ (0.23)	$ (0.39)	$ (1.45)	$ (0.83)	$ (0.52)

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts (Detail) - Allowances for Uncollectible Accounts and Sales Returns and Allowances [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	$ 93	$ 93	$ 89
Charges to Costs and Expenses	2,961	0	0
Recoveries of Costs and Expenses	(39)	0	0
Deductions to Allowances for Uncollectible Accounts	(142)	0	0
Charges to (Deductions from) Other Accounts	4	0	4
Balance at End of Year	$ 2,877	$ 93	$ 93